<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000330.pub3" GROUP_ID="PREG" ID="344399080515130958" MERGED_FROM="" MODIFIED="2013-07-08 10:43:59 +0100" MODIFIED_BY="Frances Kellie" REVIEW_NO="0178" REVMAN_SUB_VERSION="5.2.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="13.2">
<COVER_SHEET MODIFIED="2013-07-08 10:43:59 +0100" MODIFIED_BY="Frances Kellie">
<TITLE>Enemas during labour</TITLE>
<CONTACT MODIFIED="2013-07-08 10:43:59 +0100" MODIFIED_BY="Frances Kellie"><PERSON ID="14522" ROLE="AUTHOR"><FIRST_NAME>Ludovic</FIRST_NAME><LAST_NAME>Reveiz</LAST_NAME><SUFFIX>MD, MSc, PhD (Cand)</SUFFIX><POSITION>Advisor</POSITION><EMAIL_1>mmreveiz@hotmail.com</EMAIL_1><EMAIL_2>lreveiz@yahoo.com</EMAIL_2><ADDRESS><DEPARTMENT>Research Promotion and Development Team</DEPARTMENT><ORGANISATION>Health Systems Based on Primary Health Care (HSS), Pan American Health Organization</ORGANISATION><ADDRESS_1>525, 23rd St, NW</ADDRESS_1><CITY>Washington DC</CITY><ZIP>20037-2895</ZIP><COUNTRY CODE="US">USA</COUNTRY><PHONE_2>+1 202 974 3135</PHONE_2></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2013-07-08 10:43:59 +0100" MODIFIED_BY="Frances Kellie"><PERSON ID="14522" ROLE="AUTHOR"><FIRST_NAME>Ludovic</FIRST_NAME><LAST_NAME>Reveiz</LAST_NAME><SUFFIX>MD, MSc, PhD (Cand)</SUFFIX><POSITION>Advisor</POSITION><EMAIL_1>mmreveiz@hotmail.com</EMAIL_1><EMAIL_2>lreveiz@yahoo.com</EMAIL_2><ADDRESS><DEPARTMENT>Research Promotion and Development Team</DEPARTMENT><ORGANISATION>Health Systems Based on Primary Health Care (HSS), Pan American Health Organization</ORGANISATION><ADDRESS_1>525, 23rd St, NW</ADDRESS_1><CITY>Washington DC</CITY><ZIP>20037-2895</ZIP><COUNTRY CODE="US">USA</COUNTRY><PHONE_2>+1 202 974 3135</PHONE_2></ADDRESS></PERSON><PERSON ID="A6B70D5682E26AA20078D4E688395A6C" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Hernando</FIRST_NAME><MIDDLE_INITIALS>G</MIDDLE_INITIALS><LAST_NAME>Gaitán</LAST_NAME><POSITION>Titular Professor</POSITION><EMAIL_1>hggaitand@unal.edu.co</EMAIL_1><EMAIL_2>hernando.gaitan@gmail.com</EMAIL_2><URL>http://sticr.cochrane.org/</URL><ADDRESS><DEPARTMENT>Department of Obstetrics &amp; Gynecology and Clinical Research Institute, Faculty of Medicine</DEPARTMENT><ORGANISATION>National University of Colombia</ORGANISATION><ADDRESS_1>Carrera 30 No. 45-03</ADDRESS_1><CITY>Bogota</CITY><COUNTRY CODE=" CO">Colombia</COUNTRY><PHONE_1>+57 1 3165000</PHONE_1></ADDRESS></PERSON><PERSON ID="D34EDBC282E26AA20080535F3A0DAD03" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Luis Gabriel</FIRST_NAME><LAST_NAME>Cuervo</LAST_NAME><EMAIL_1>cuervolu@paho.org</EMAIL_1><EMAIL_2>lgcuervo@gmail.com</EMAIL_2><URL>http://www.linkedin.com/in/lgcuervo</URL><MOBILE_PHONE>+1 (202) 213-7402</MOBILE_PHONE><ADDRESS><DEPARTMENT>Research Promotion Team and Development</DEPARTMENT><ORGANISATION>Pan American Health Organization (PAHO/WHO)</ORGANISATION><ADDRESS_1>525 23rd St NW</ADDRESS_1><CITY>Washington DC</CITY><ZIP>20037-2895</ZIP><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 202 9743135</PHONE_1><PHONE_2>+1 202 9743000</PHONE_2></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2013-07-04 15:44:44 +0100" MODIFIED_BY="Sonja Henderson">
<UP_TO_DATE>
<DATE DAY="4" MONTH="7" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="31" MONTH="5" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="28" MONTH="3" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="1997"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="1999"/>
<LAST_CITATION_ISSUE ISSUE="5" YEAR="2013"/>
</DATES>
<WHATS_NEW MODIFIED="2013-06-29 11:58:53 +0100" MODIFIED_BY="Denise Atherton">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2013-06-29 11:53:26 +0100" MODIFIED_BY="Sonja Henderson">
<DATE DAY="29" MONTH="6" YEAR="2013"/>
<DESCRIPTION>
<P>Review updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-06-29 11:58:53 +0100" MODIFIED_BY="Sonja Henderson">
<DATE DAY="29" MONTH="6" YEAR="2013"/>
<DESCRIPTION>
<P>Search updated in May 2013. No new trials identified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-06-29 11:49:57 +0100" MODIFIED_BY="Denise Atherton">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2013-06-29 11:49:52 +0100" MODIFIED_BY="Sonja Henderson">
<DATE DAY="1" MONTH="11" YEAR="2012"/>
<DESCRIPTION>
<P>Review updated but no new trials included.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-06-29 11:49:57 +0100" MODIFIED_BY="Sonja Henderson">
<DATE DAY="17" MONTH="5" YEAR="2012"/>
<DESCRIPTION>
<P>Search updated in May 2012. One new trial identified and excluded (<LINK REF="STD-Lurie-2012" TYPE="STUDY">Lurie 2012</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-05-17 16:16:30 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="18" MONTH="1" YEAR="2012"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-02-09 15:32:13 +0000" MODIFIED_BY="Denise Atherton">
<DATE DAY="28" MONTH="2" YEAR="2010"/>
<DESCRIPTION>
<P>Search updated, which identified one new RCT (<LINK REF="STD-Clarke-2007" TYPE="STUDY">Clarke 2007</LINK>). There are now a total of four trials included in the review. The inclusion of the new included study did not change the overall conclusions. In addition, a 'Risk of bias' assessment was performed for all RCTs.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-02-07 20:43:20 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="12" MONTH="5" YEAR="2009"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-05-12 11:58:35 +0100" MODIFIED_BY="Denise Atherton">
<DATE DAY="2" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2008-10-16 16:58:29 +0100" MODIFIED_BY="Sonja Henderson">
<DATE DAY="30" MONTH="7" YEAR="2007"/>
<DESCRIPTION>
<P>New authors.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2010-03-08 20:24:12 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="4" YEAR="2007"/>
<DESCRIPTION>
<P>This update is based on a search run in March 2007, which identified one new included study (<LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>) and two new excluded studies (<LINK REF="STD-Lopes-2001" TYPE="STUDY">Lopes 2001</LINK>; <LINK REF="STD-Tzeng-2005" TYPE="STUDY">Tzeng 2005</LINK>).<BR/>
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2013-04-10 12:54:51 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-07-08 10:41:29 +0100" MODIFIED_BY="Denise Atherton">
<SUMMARY MODIFIED="2013-02-10 15:57:43 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-09-02 12:13:01 +0100" MODIFIED_BY="Frances J Kellie">Enemas during labour</TITLE>
<SUMMARY_BODY MODIFIED="2013-02-10 15:57:43 +0000" MODIFIED_BY="[Empty name]">
<P>Scientific research evidence does not support the routine use of enemas during the first stage of labour.</P>
<P>Giving women enemas during labour has been routine practice in delivery wards of many countries and settings. Occasionally women leak from their back passage whilst giving birth and it was thought an enema in early labour would reduce this soiling and the consequent embarrassment for women. It was also thought that emptying the back passage would give more room for the baby to be born, would reduce the length of labour and would reduce the chance of infection for both the mother and the baby. It was also suggested it would reduce bowel movements after birth which often cause women concern. The disadvantages suggested were that it is a very unpleasant procedure and causes increased pain for women during labour and because enemas could produce a watery faecal soiling whilst giving birth, they could potentially increase the risk of infections. The review identified four studies involving 1917 women. These studies found no significant differences in any of the outcomes assessed either for the woman or the baby. However, none of the trials assessed pain for the woman during labour and there were insufficient data to assess rare adverse outcomes. Thus the evidence speaks against the routine use of enemas during labour.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-07-04 15:45:54 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2012-11-26 10:33:31 +0000" MODIFIED_BY="[Empty name]">
<P>Although the use of enemas during labour usually reflects the preference of the attending healthcare provider, enemas may cause discomfort for women.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2012-06-25 13:33:04 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effects of enemas applied during the first stage of labour on maternal and neonatal outcomes.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-07-04 15:45:54 +0100" MODIFIED_BY="Lynn Hampson">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 May 2013), the Cochrane Central Register of Controlled Trials and Database of Abstracts of Reviews of Effectiveness (<I>The Cochrane Library</I> 2013, Issue 5), PubMed (1966 to 31 May 2013), LILACS (31 May 2013), the Search Portal of the International Clinical Trials Registry Platform (ICTRP) (31 May 2013), Health Technology Assessment Program, UK (31 May 2013), Medical Research Council, UK (31 May 2013), The Wellcome Trust, UK (31 May 2013) and reference lists of retrieved articles.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2013-02-10 15:56:52 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised controlled trials (RCTs) in which an enema was administered during the first stage of labour and which included assessment of possible neonatal or puerperal morbidity or mortality.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-02-10 15:56:52 +0000" MODIFIED_BY="Sonja L  Henderson">
<P>Two review authors independently assessed studies for inclusion. </P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-02-10 15:57:25 +0000" MODIFIED_BY="[Empty name]">
<P>Four RCTs (1917 women) met the inclusion criteria. One study was judged as having a low risk of bias. In the meta-analysis we conducted of two trials, we found no significant difference in infection rates for puerperal women (two RCTs; 594 women; risk ratio (RR) 0.66, 95% confidence (CI) 0.42 to 1.04). No significant differences were found in neonatal umbilical infection rates (two RCTs; 592 women; RR 3.16, 95% CI 0.50 to 19.82; I² 0%. In addition, meta-analysis of two studies found that there were no significant differences in the degree of perineal tear between groups. Finally, meta-analysis of two trials found no significant differences in the mean duration of labour.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-02-10 15:57:15 +0000" MODIFIED_BY="Jill V Hampson">
<P>The evidence provided by the four included RCTs shows that enemas do not have a significant beneficial effect on infection rates such as perineal wound infection or other neonatal infections and women's satisfaction. These findings speak against the routine use of enemas during labour, therefore, such practice should be discouraged.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-07-04 15:46:33 +0100" MODIFIED_BY="Denise Atherton">
<BACKGROUND MODIFIED="2013-02-10 15:58:54 +0000" MODIFIED_BY="[Empty name]">
<P>Enemas are frequently used in obstetric settings depending on the preference of, and the resources available to, the person attending the delivery (<LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>; <LINK REF="STD-Drayton-1984" TYPE="STUDY">Drayton 1984</LINK>). Several consumer web pages on the Internet widely recommend their use in labour (<LINK REF="REF-Curtis-2007" TYPE="REFERENCE">Curtis 2007</LINK>; <LINK REF="REF-PregnancyWeekly.com" TYPE="REFERENCE">PregnancyWeekly.com</LINK>). Since this intervention may generate discomfort to women, increase the cost of delivery, and the workload on wards, an evaluation of the effectiveness of enemas during labour is important. A survey that evaluated the use of routine interventions and practices in labour and birth as reported by women in the Maternity Experiences Survey of the Canadian Perinatal Surveillance System found that 5.4% (95% confidence interval 4.7 to 6.0) of women reported having an enema. The authors also found that there were regional variations in rates ranging from 1.9% to 13.0% and that younger (15 to 19 years) and older (aged 40 years and older) women having their first baby, or with lower levels of education and family income were more likely to report having had an enema (<LINK REF="REF-Chalmers-2009" TYPE="REFERENCE">Chalmers 2009</LINK>). Other studies conducted in South East Asia countries (<LINK REF="REF-SEA_x002d_ORCHID-Study-Group-2008" TYPE="REFERENCE">SEA-ORCHID Study Group 2008</LINK>), Colombia (<LINK REF="REF-Conde_x002d_Agudelo-2008" TYPE="REFERENCE">Conde-Agudelo 2008</LINK>), Brazil (<LINK REF="REF-Sodr_x00e9_-2007" TYPE="REFERENCE">Sodré 2007</LINK>) and Jordan (<LINK REF="REF-Sweidan-2008" TYPE="REFERENCE">Sweidan 2008</LINK>) found high rates of unnecessary practices of enema in labour. Another study reported that 37% of hospitals (193/521) had a "no enema/suppository" policy on admission in 2003 while 88% (282/322) did have in 2007 (<LINK REF="REF-Levitt-2011" TYPE="REFERENCE">Levitt 2011</LINK>).</P>
<P>Some researchers (<LINK REF="STD-Lopes-2001" TYPE="STUDY">Lopes 2001</LINK>; <LINK REF="STD-Romney-1981" TYPE="STUDY">Romney 1981</LINK>) have proposed that enemas should be used because:<BR/>(i) they will lessen the degree of contamination of broken skin with faeces, thus reducing puerperal infections;<BR/>(ii) women may regard cleaning their bowels as something good;<BR/>(iii) they hope that they may diminish neonatal and puerperal infection rates by reducing contamination with faeces;<BR/>(iv) for women who have not opened their bowels in the previous 24 hours and have an obviously loaded rectum on initial pelvic examination, bowel movement soon after delivery may cause discomfort with an episiotomy.</P>
<P>Others (<LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>) have opposed the use of enemas on the basis of:<BR/>(i) unproven effectiveness;<BR/>(ii) watery faeces may increase contamination, potentially increasing maternal and neonatal infections;<BR/>(iii) it is widely accepted that this intervention generates discomfort to women and increases the costs of care.</P>
<P>The effectiveness of enemas has been measured using different maternal and neonatal outcomes such as puerperal (approximate six-week period lasting from childbirth to the return of normal uterine size) infections and/or neonatal (relating to the first 28 days of life) infections. The duration of follow-up depends on the measured maternal or neonatal outcome; in one study (<LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>) the primary outcomes were the diagnosis of infections in newborns or women during the month following delivery.</P>
<P>Enemas may also add to the workload of delivery wards and increase the cost of delivery. Enemas are known to cause discomfort and it is unclear if their potential benefit exceeds their inconvenience, cost and potential harms (<LINK REF="REF-Yeat-2011" TYPE="REFERENCE">Yeat 2011</LINK>). Rare serious adverse events, such as perforations of the rectosigmoid colon or septic shock induced by cleansing enemas have been reported, usually in older women (<LINK REF="REF-Gayer-2002" TYPE="REFERENCE">Gayer 2002</LINK>; <LINK REF="REF-Paran-1999" TYPE="REFERENCE">Paran 1999</LINK>). Considering that there are opposing views and theories, and uncertainties about the use of this intervention, scientific methods are needed to assess the effects of enemas to allow people to make a well-informed choice. We considered it was therefore important to assess the effects of enemas used during labour on women and newborn.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-06-25 13:37:59 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effects of enemas applied during the first stage of labour on maternal and neonatal outcomes.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-07-04 15:46:33 +0100" MODIFIED_BY="Denise Atherton">
<SELECTION_CRITERIA MODIFIED="2013-02-11 11:54:49 +0000" MODIFIED_BY="Frances J Kellie">
<CRIT_STUDIES MODIFIED="2013-02-10 15:59:15 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised controlled trials comparing the use of enema versus no enema, or comparing different types of enemas.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Women during the first stage of labour.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Enemas (of high or low volume, soapsuds, saline solutions, medicated or tap water).</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-02-11 11:54:49 +0000" MODIFIED_BY="Frances J Kellie">
<P>We planned to measure the effectiveness of enemas at four to six weeks of birth. However, we also collected data on different follow-up periods depending on the trialists report.</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2013-02-11 11:54:49 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">Maternal or neonatal mortality</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Puerperal outcomes</HEADING>
<OL>
<LI>Complications of episiotomy and perineal tears such as episiotomy dehiscence (splitting of a surgical wound) or infection (i.e. purulent effusion from perineal tears).</LI>
<LI>Endometritis (i.e. fever and purulent vaginal discharge).</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Neonatal outcomes</HEADING>
<OL>
<LI>Neonatal infections such as: umbilical infection (foul smell with periumbilical erythema (redness of the skin)); respiratory tract infections (any infection of the respiratory tract, i.e. lower and/or upper tract); meningitis (serious inflammation of the meninges); or sepsis (as defined by trialists).</LI>
</OL>
</SUBSECTION>
</SUBSECTION>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2013-02-10 15:59:45 +0000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Perineal wound repair.</LI>
<LI>Perineal tear/episiotomy wound (not a pre-specified outcome).</LI>
<LI>Need for any analgesia during labour.</LI>
<LI>Economic outcomes.</LI>
<LI>Duration of labour and its different stages.</LI>
<LI>One-minute Apgar of the newborn.</LI>
<LI>Five-minute Apgar of the newborn.</LI>
<LI>Faecal soiling during first stage of labour.</LI>
<LI>Faecal soiling during delivery.</LI>
<LI>Duration of labour and labour stages.</LI>
<LI>Levels of satisfaction of parturients and\or medical staff (not a pre-specified outcome).</LI>
<LI>Overall pain during labour (not a pre-specified outcome).</LI>
<LI>Other pelvic Infections (infections involving the tissues or organs in the pelvis i.e. vulvovaginitis, myometritis etc.).</LI>
<LI>Urinary tract infection.</LI>
<LI>Other puerperal infections.</LI>
<LI>Need for systemic antibiotics (maternal and neonatal).</LI>
<LI>Other neonatal infections (not a pre-specified outcome).</LI>
<LI>Ophthalmic infection (i.e. purulent drainage in the eye after the sixth day of delivery) or dacryocystitis (inflammation of the lacrimal sac).</LI>
<LI>Skin infections (i.e. cellulitis or impetigo).</LI>
<LI>Intestinal infections.</LI>
<LI>Rare serious adverse effects (i.e. perforations of the rectosigmoid colon or septic shock. Not a pre-specified outcome).</LI>
<LI>Delivery type (caesarean section) (not a pre-specified outcome).</LI>
<LI>Birthweight (not a pre-specified outcome).</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-07-04 15:46:33 +0100" MODIFIED_BY="Lynn Hampson">
<ELECTRONIC_SEARCHES MODIFIED="2013-07-04 15:46:33 +0100" MODIFIED_BY="Lynn Hampson">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register by contacting the Trials Search Co-ordinator (31 May 2013).</P>
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from: </P>
<OL>
<LI>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE;</LI>
<LI>weekly searches of Embase;</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A>. </P>
<P>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords. </P>
<P>In addition, we searched CENTRAL and the Database of Abstracts of Reviews of Effectiveness (DARE) (<I>The Cochrane Library</I> 2013, Issue 5), PubMed (1966 to 31 May 2013), LILACS (1982 to 31 May 2013) using the search strategy listed in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<P>In order to further identify ongoing RCTs and unpublished studies, we searched the following databases (31 May 2013).<BR/>
</P>
<UL>
<LI>Search Portal of the International Clinical Trials Registry Platform (<A HREF="http://www.who.int/ictrp/">ICTRP</A>)</LI>
<LI>Health Technology Assessment Program <A HREF="http://www.hta.ac.uk/">(HTA)</A> [United Kingdom]</LI>
<LI>
<A HREF="http://www.mrc.ac.uk/index.htm">Medical Research Council</A> [United Kingdom]</LI>
<LI>
<A HREF="http://www.wellcome.ac.uk">The Wellcome Trust</A> [United Kingdom]</LI>
</UL>
<P>
<I>See: </I>
<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for search strategy used.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2013-02-10 16:00:05 +0000" MODIFIED_BY="Lynn Hampson">
<P>We also searched the reviews previously published in the Cochrane Pregnancy and Childbirth database on enemas (<LINK REF="REF-Hay_x002d_Smith-1995a" TYPE="REFERENCE">Hay-Smith 1995a</LINK>; <LINK REF="REF-Hay_x002d_Smith-1995b" TYPE="REFERENCE">Hay-Smith 1995b</LINK>; <LINK REF="REF-Hay_x002d_Smith-1995c" TYPE="REFERENCE">Hay-Smith 1995c</LINK>; <LINK REF="REF-Hay_x002d_Smith-1995d" TYPE="REFERENCE">Hay-Smith 1995d</LINK>).</P>
<P>We did not apply any language restrictions.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-02-20 14:37:49 +0000" MODIFIED_BY="Denise Atherton">
<P>For the methods to be used to assess trials identified in the future updates, <I>see </I>
<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="3">1. Study selection</HEADING>
<P>One review author, Ludovic Reveiz (LR), checked the titles and abstracts identified from the searches. If it was clear that the study was not a randomised controlled trial (RCT) evaluating enemas in pregnant women during labour, we excluded it. If we were unclear about the above, then two review authors assessed the full report of the study independently (LR and Hernando Gaitan (HG)) to determine if it fulfilled the inclusion criteria. The two authors resolved disagreements by consensus. Otherwise, we would have consulted the third review author (Luis Gabriel Cuervo) but this situation did not happen. The table <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> lists the reasons behind the exclusion of trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">2. Risk of bias assessment</HEADING>
<P>Two review authors (LR, HG) independently assessed risk of bias for each study as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We planned to resolve disagreements through dialogue leading to consensus and if we could not reach the latter, to invite the third review author to weigh in to decide by majority. We considered the possible sources of bias described below and assessed these in the 'Risk of bias' table for each included study. We classified each one of these sources as of low, high or unclear risk of bias by answering 'yes', 'no' or 'unclear' to each one of the items in the 'Risk of bias' table. Whenever possible, we gave more information about these answers using the 'Description' boxes with a clarifying comment or a quoted sentence taken directly from the original article.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Sequence generation</HEADING>
<P>We described, for each included study, the methods used to generate the allocation sequence in sufficient detail to allow an assessment of whether it produced comparable groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(2) Allocation concealment</HEADING>
<P>We described, for each included study, the methods used to conceal the allocation sequence in sufficient detail, and therefore, determined whether the intervention allocation could have been foreseen before, or during recruitment, or changed after assignment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3) Blinding of participants, healthcare professionals and outcome assessors</HEADING>
<P>We described, for each included study, the methods used to blind study participants, healthcare professionals and outcome appraisers to the intervention the participant received. We also provided information on whether the intended blinding was effective. If blinding was unclear, we assessed whether the information provided was likely to have introduced bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data</HEADING>
<P>We described, for each included study the completeness of data. We assessed whether incomplete data were adequately addressed.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting</HEADING>
<P>We described, for each included study, the possibility that outcomes were selectively reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other potential sources of bias</HEADING>
<P>We described, for each included study, any important concerns about other possible sources of bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>We made explicit judgements about whether studies were at high, moderate or low risk of bias, according to the criteria given in the <I>Handbook</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). With reference to (1) to (6) above, we estimated the magnitude and direction of the bias and whether we considered it was likely to have impacted on the findings.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">3. Data extraction</HEADING>
<P>Two review authors (LR and HG) carried out data extraction using a pre-designed data extraction form. We resolved disagreements among all three review authors. We actively sought missing data from authors using their registered contact details, plus complementary Internet searches when needed. We included these data if retrieved.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">4. Analysis</HEADING>
<P>To estimate statistical differences between treatments, we pooled the results of RCTs that assessed the effects of similar interventions, and calculated a weighted-treatment effect across RCTs using the fixed-effect model. We expressed the results as follows:</P>
<OL>
<LI>for dichotomous outcomes: as risk ratio (RR) (RCTs, participants; RR, 95% confidence intervals (CI));</LI>
<LI>for continuous outcomes: as mean difference (MD) (RCTs; participants; MD and 95% CI).</LI>
</OL>
<P>We expressed results as number needed to treat where appropriate. We summarised available information in accordance with the review protocol. We identified and listed quasi-randomised and non-randomised controlled studies for reference, but we did not discuss them further. To provide a better balance of information, we also included qualitative descriptions of available information on adverse effects, when possible. We reported results as rate ratios. We imputed conservative standard deviations where necessary using the P value from an independent two-sample T-test (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). For the pooled analysis, we calculated the I² statistic, which describes the percentage of total variation across studies caused by heterogeneity; less than 25% was considered as low level heterogeneity; 25% to 50% as moderate level, and higher than 50% as high level heterogeneity (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-07-01 14:34:11 +0100" MODIFIED_BY="Denise Atherton">
<STUDY_DESCRIPTION MODIFIED="2013-07-01 14:34:11 +0100" MODIFIED_BY="Denise Atherton">
<SEARCH_RESULTS MODIFIED="2013-07-01 14:34:11 +0100" MODIFIED_BY="[Empty name]">
<P>The search identified 102 references. An initial trawl through this list, undertaken by two review authors, excluded 90 references that did not comply with the inclusion criteria. We screened 12 trials: we excluded eight and included four RCTs that recruited a total of 1917 women. For this update we did not identify any additional trials for inclusion. The search of clinical trial registers (International Clinical Trials Registry Platform) identified 78 trials but found no ongoing RCTs complying with the inclusion criteria.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2013-02-10 16:00:34 +0000" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Drayton-1984" TYPE="STUDY">Drayton 1984</LINK>: the RCT was conducted at the University Hospital of Wales, Cardiff (UK). The characteristics of participating women are poorly described. Inclusion criteria were fulfilled by 370 women invited to participate, of whom 222 (60%) agreed to randomisation. The intervention group received a low-volume disposable phosphate enema during the first stage of labour. Caesarean section rates were not described in this study. Randomisation was stratified between primigravidae (43%) and multigravidae (57%).</P>
<P>
<LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>: this RCT was conducted in Thailand; 1100 term-pregnant women admitted for delivery were randomly allocated to receive either enema or no enema (539 participants to enema and 561 participants to no enema) from 1 February 2002 to 15 June 2002. Stratification by parity was not done. Seventy-three women, who delivered by caesarean section due to obstetric indications after an unsuccessful trial of labour were excluded (39 with enema versus 34 with no enema). Newborns were followed up for four days through clinical observation during hospitalisation to assess neonatal infections. We were unable to reach the authors by e-mail when we sought additional information. The authors measured satisfaction level in pregnant women and medical staff with Likert scales with scores ranked as: excellent, good, average, fair or poor.</P>
<P>
<LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>: this RCT was conducted in a tertiary care referral hospital in Bogota, Colombia. Of the women invited to participate, 16 were not eligible and one declined to participate. In total, 443 women were randomised, achieving well-balanced groups (221 allocated to enema versus 222 to control) from February 1997 to February 1998. Twelve per cent of the participants had a caesarean section. Stratification by parity was done. The RCT did not evaluate women's preferences or known adverse effects of enemas, such as pain, discomfort, embarrassment or diarrhoea.</P>
<P>
<LINK REF="STD-Clarke-2007" TYPE="STUDY">Clarke 2007</LINK>: this RCT was conducted in the United States; 152 pregnant women admitted for delivery were randomly allocated to receive either standardised enema soap solution within 30 minutes of enrolment or no enema (75 women to enema and 77 to no enema). The characteristics of participating women are poorly described. The primary outcome was the time interval from enrolment to delivery. Secondary outcomes included intrapartum infection rate, faecal soiling at delivery, mode of delivery and patient satisfaction.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2013-02-09 16:02:02 +0000" MODIFIED_BY="[Empty name]">
<P>Eight studies were excluded from the review for different reasons including non-randomised studies, inadequate randomisation, different type of participants or interventions (see <LINK TAG="EXCLUDED_STUDIES_DESCR" TYPE="SECTION">Excluded studies</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-02-10 16:00:55 +0000" MODIFIED_BY="[Empty name]">
<ALLOCATION MODIFIED="2013-02-10 16:00:40 +0000" MODIFIED_BY="[Empty name]">
<P>The allocation strategy and the method of allocation concealment were considered adequate for one trial (<LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>) and unclear for the other three (<LINK REF="STD-Clarke-2007" TYPE="STUDY">Clarke 2007</LINK>; <LINK REF="STD-Drayton-1984" TYPE="STUDY">Drayton 1984</LINK>; <LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2012-11-08 20:29:53 +0000" MODIFIED_BY="[Empty name]">
<P>Blinding was not used in any of the four trials. </P>
</BLINDING>
<EXCLUSIONS MODIFIED="2013-02-10 16:00:55 +0000" MODIFIED_BY="[Empty name]">
<P>Two studies were considered to have low risk of bias (<LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>; <LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>) while the other two had an unclear risk of bias (<LINK REF="STD-Clarke-2007" TYPE="STUDY">Clarke 2007</LINK>; <LINK REF="STD-Drayton-1984" TYPE="STUDY">Drayton 1984</LINK>).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2012-12-11 16:39:58 +0000" MODIFIED_BY="[Empty name]">
<P>The study protocol was not available for any of the studies.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2013-02-10 16:00:55 +0000" MODIFIED_BY="[Empty name]">
<P>One study had a high risk of bias (<LINK REF="STD-Drayton-1984" TYPE="STUDY">Drayton 1984</LINK>), while one was judged as having unclear (<LINK REF="STD-Clarke-2007" TYPE="STUDY">Clarke 2007</LINK>) and two low risk of bias (<LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>; <LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>).</P>
<P>Overall, only one study was judged as having low risk of bias (<LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>). A brief description is provided for each study (see <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). For more details, <I>see</I> <LINK TAG="STUDY_QUALITY" TYPE="SECTION">Risk of bias in included studies</LINK>.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-02-10 16:01:03 +0000" MODIFIED_BY="Denise Atherton">
<SUBSECTION>
<HEADING LEVEL="3">Enema versus no enema</HEADING>
<P>Four trials, involving 1917 women, fulfilled the inclusion criteria for the review: <LINK REF="STD-Drayton-1984" TYPE="STUDY">Drayton 1984</LINK>, (222 women); <LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>, (1100 women); <LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>, (443 women) and <LINK REF="STD-Clarke-2007" TYPE="STUDY">Clarke 2007</LINK> (152 women). Findings of individual trials are found in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>No significant differences were found in neonatal umbilical infection rates (two RCTs ; 592 women; risk ratio (RR) 3.16, 95% confidence interval (CI) 0.50 to 19.82; I² 0%; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>). However, these results should be interpreted with caution as one of the studies (<LINK REF="STD-Drayton-1984" TYPE="STUDY">Drayton 1984</LINK>) did not report time of follow-up of participants and did not describe the means to assess infections.</P>
<P>No significant differences were found for any other primary outcomes.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<P>In meta-analyses of two studies there were no significant differences in the degree of perineal tear between groups (<LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>; <LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>) (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>; <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>). In the meta-analysis we conducted of two trials (<LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>; <LINK REF="STD-Drayton-1984" TYPE="STUDY">Drayton 1984</LINK>), we found no significant difference in infection rates for puerperal women (two RCTs; 594 women; RR 0.66, 95% CI 0.42 to 1.04; <LINK REF="CMP-001.32" TYPE="ANALYSIS">Analysis 1.32</LINK>). Finally, meta-analysis of two trials (<LINK REF="STD-Clarke-2007" TYPE="STUDY">Clarke 2007</LINK>; <LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>) found no significant differences in the mean duration of labour (<LINK REF="CMP-001.21" TYPE="ANALYSIS">Analysis 1.21</LINK>); however heterogeneity was very high (I² 95%).</P>
<P>There was less faecal soiling (one RCT; 152 women; RR 0.36, 95% CI 0.17 to 0.75; <LINK REF="CMP-001.20" TYPE="ANALYSIS">Analysis 1.20</LINK>), higher satisfaction levels of labour attendants, accoucheurs and perineorrhaphy operators (one RCT; 1027 women; mean difference (MD) 0.17, 95% 0.08 to 0.26; MD 0.26, 95% 015 to 0.37; MD 0.11, 95% 0.02 to 0.20; <LINK REF="CMP-001.24" TYPE="ANALYSIS">Analysis 1.24</LINK>; <LINK REF="CMP-001.25" TYPE="ANALYSIS">Analysis 1.25</LINK>; <LINK REF="CMP-001.26" TYPE="ANALYSIS">Analysis 1.26</LINK>) and more intrapartum infection rates (one RCT; 152 women; RR 4.62, 95% CI 1.03 to 20.68; <LINK REF="CMP-001.33" TYPE="ANALYSIS">Analysis 1.33</LINK>) in the group of women randomised to receive enemas compared to those that did not.</P>
<P>No significant differences were found for any other secondary outcomes.</P>
<P>The four RCTs did not report any serious adverse event.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Enema versus different type of enema</HEADING>
<P>No trials were found.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-02-10 16:01:11 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2013-01-11 21:51:48 +0000" MODIFIED_BY="[Empty name]">
<P>The objective of this review was to address the effects of enemas during the first stage of labour. The use of enema does not result in improved maternal or neonatal outcomes: there was no difference in the rate of infection, such as perineal wound infection and neonatal infection. Pooled results of two trials (<LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>; <LINK REF="STD-Drayton-1984" TYPE="STUDY">Drayton 1984</LINK>) found no significant difference in infection rates for puerperal women, in the rate of neonatal umbilical infection, differences in the degree of perineal tear between groups (<LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>; <LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>) or in the mean duration of labour (<LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>; <LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>).</P>
</SUMMARY_OF_RESULTS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-02-10 16:01:11 +0000" MODIFIED_BY="[Empty name]">
<P>The quality of the evidence available for comparisons was high to moderate, mainly because there were only one or two studies for each treatment comparison and main results were imprecise in some cases, as reflected in wide confidence intervals.</P>
<P>Even though blinding of outcome assessors was not done, it is unlikely that this had any influence on the assessment of objective outcome measures most relevant to patients, specifically, infection outcomes. However, other subjective outcomes such as levels of satisfaction, could be open to biased assessments. Similarly, the selection of patients by the recruiter may have been influenced by the lack of allocation concealment in three of the four studies.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2013-02-10 16:01:11 +0000" MODIFIED_BY="[Empty name]">
<P>It is unlikely that publication bias is an issue, given that all included studies presented results not favourable for the more active interventions. Also, the search strategy was very comprehensive, including a search of the most important clinical trials registers. Contact with the authors of the included studies was made, and data were analysed and extracted independently by at least two review authors.</P>
<P>All relevant data for the objectives of this review were available from the publications of included studies. However, given that there was not an increased risk of specific types of infection with the interventions, it might be more relevant to use outcomes that reflect severity and timing of infection, rather than specific infections (i.e. whether before or after discharge from hospital after birth, need for antibiotics, or admission to special care). We will address this issue in the next update.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2012-11-29 16:00:59 +0000" MODIFIED_BY="[Empty name]">
<P>Our review provides evidence derived from four trials using different outcomes. The findings provide grounds against the routine administration of enemas during labour. These are in line with the findings from quasi-experimental studies (<LINK REF="STD-Lopes-2001" TYPE="STUDY">Lopes 2001</LINK>; <LINK REF="STD-Tzeng-2005" TYPE="STUDY">Tzeng 2005</LINK>). The results suggest that it is unlikely that enemas have any beneficial effects on clinical outcomes large enough to outweigh the inconvenience, costs or potential adverse effects.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2012-11-29 16:00:26 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2012-11-29 16:00:14 +0000" MODIFIED_BY="[Empty name]">
<P>This review found that enemas did not improve puerperal or neonatal infection rates, episiotomy dehiscence rates or maternal satisfaction. Therefore, their use is unlikely to benefit women or newborn children, and there is no reliable scientific basis to recommend their routine use. Routine enemas should only be offered or advocated if there is clear evidence of benefit. In the absence of such evidence, these findings should discourage the routine use of enemas during labour.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-11-29 16:00:26 +0000" MODIFIED_BY="[Empty name]">
<P>No additional research may be necessary to assess the overall effects of enemas in maternal or neonatal outcomes unless there is a need to assess their effects on a specific outcome. Routine enemas are not a priority topic for future research. The existing studies may have been underpowered to assess specific outcomes but, considering that these outcomes may be uncommon, the studies would require huge sample sizes making it unlikely that any findings would swing the balance as far as making the benefits outweigh potential harms, costs and inconvenience. If additional studies were to be carried out, these should perhaps focus on other factors that may be influencing the use of enemas, such as women's perceptions, pain, inconvenience, costs or any other non-clinical motivations.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-07-08 10:41:29 +0100" MODIFIED_BY="[Empty name]">
<P>We would like to thank Lynn Hampson for her assistance with the search for trials and Sonja Henderson, Denise Atherton and Rebecca Smyth from the Cochrane Pregnancy and Childbirth Group.</P>
<P>This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 2013, Issue 7. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Review.</P>
<P>The Pan American Health Organization and Hernando G Gaitán retain copyright and all other rights in their respective contributions to the manuscript of this Review as submitted for publication.</P>
<P>The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Pregnancy and Childbirth Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR, NHS or the Department of Health.<BR/>
</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2013-04-10 12:53:26 +0100" MODIFIED_BY="[Empty name]">
<P>Dr Luis Gabriel Cuervo conducted a randomised controlled trial included in this review. His study fulfilled the inclusion criteria for this review. For this review, he was not involved in the selection of studies or in the appraisal of his study. Information from this study was independently collected and appraised by the other review authors.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-07-04 14:49:24 +0100" MODIFIED_BY="Sonja Henderson">
<P>All authors approved the final version of the 2013 update.</P>
<P>Ludovic Reveiz assessed the identified papers, drafted the conclusions and contributed to the writing of the review. He ensured the appropriate use of the statistical tests used and extracted the data. Ludovic Reveiz is now the guarantor of the review.</P>
<P>Hernando Gaitan assessed the identified papers, drafted the conclusions and contributed to the writing of the review.</P>
<P>Luis Gabriel Cuervo led the development of the first version and the first update of the review and commented on drafts of this update.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2013-06-29 12:25:47 +0100" MODIFIED_BY="[Empty name]">
<P>Levels of satisfaction of parturients and medical staff, delivery types (caesarean section), other neonatal infections, perineal tear/episiotomy wound, serious adverse effects, respiratory infection, overall pain during labour and birthweight were not pre-specified outcomes but were included in the review as secondary outcomes. </P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-07-04 11:02:06 +0100" MODIFIED_BY="Denise Atherton">
<STUDIES MODIFIED="2013-02-09 15:23:32 +0000" MODIFIED_BY="Jill V Hampson">
<INCLUDED_STUDIES MODIFIED="2010-03-11 11:41:19 +0000" MODIFIED_BY="Jill V Hampson">
<STUDY DATA_SOURCE="PUB" ID="STD-Clarke-2007" MODIFIED="2010-02-17 02:05:21 +0000" MODIFIED_BY="[Empty name]" NAME="Clarke 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-02-17 02:05:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clarke NT, Jenkins TR</AU>
<TI>Randomized prospective trial of the effects of an enema during labor [abstract]</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2007</YR>
<VL>109</VL>
<NO>4 Suppl</NO>
<PG>7S</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cuervo-2006" MODIFIED="2010-03-11 11:41:19 +0000" MODIFIED_BY="Jill V Hampson" NAME="Cuervo 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-03-11 11:41:19 +0000" MODIFIED_BY="Jill V Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cuervo LG, Bernal MP, Mendoza N</AU>
<TI>Effects of high volume saline enemas vs no enema during labour &#8211; the N-Ma randomised controlled trial</TI>
<SO>BMC Pregnancy and Childbirth</SO>
<YR>2006</YR>
<VL>6</VL>
<PG>8</PG>
<IDENTIFIERS MODIFIED="2010-03-11 11:40:39 +0000" MODIFIED_BY="Jill V Hampson"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Drayton-1984" NAME="Drayton 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;[1461]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Drayton S, Rees C</AU>
<TI>They know what they're doing. Do nurses know why they give pregnant women enemas?</TI>
<SO>Nursing Mirror</SO>
<YR>1984</YR>
<VL>159</VL>
<NO>5</NO>
<PG>4-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kovavisarach-2005" NAME="Kovavisarach 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kovavisarach E, Sringamvong W</AU>
<TI>Enema versus no-enema in pregnant women on admission in labor: a randomized controlled trial</TI>
<SO>Journal of the Medical Association of Thailand</SO>
<YR>2005</YR>
<VL>88</VL>
<NO>12</NO>
<PG>1763-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-02-09 15:23:32 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Lopes-2001" NAME="Lopes 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lopes MHB, Silva MAS, Christoforo FFM, Andrade DCJ, Bellini NR, Cervi RC</AU>
<TI>The use of intestinal cleansers to prepare for labor: analysis of advantages and disadvantages</TI>
<TO>O uso do enteroclisma no preparo para o parto: análise de suas antagens e desvantagens</TO>
<SO>Revista Latino-Americana de Enfermagem</SO>
<YR>2001</YR>
<VL>9</VL>
<NO>6</NO>
<PG>49-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lurie-2012" MODIFIED="2013-02-09 15:18:35 +0000" MODIFIED_BY="[Empty name]" NAME="Lurie 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-02-09 15:18:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lurie S, Baider C, Glickman H, Golan A, Sadan O</AU>
<TI>Are enemas given before cesarean section useful? A prospective randomized controlled study</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>2012</YR>
<VL>163</VL>
<NO>11</NO>
<PG>27-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mathie-1959" MODIFIED="2013-02-09 15:21:57 +0000" MODIFIED_BY="Heather Maxwell" NAME="Mathie 1959" YEAR="1959">
<REFERENCE MODIFIED="2013-02-09 15:21:57 +0000" MODIFIED_BY="Heather Maxwell" NOTES="&lt;p&gt;[159]&lt;/p&gt;" NOTES_MODIFIED="2013-02-09 15:21:57 +0000" NOTES_MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mathie JG, Dawson BH</AU>
<TI>Effect of castor oil, soap enema and hot bath on the pregnant human uterus near term. A tocographic study</TI>
<SO>Britiish Medical Journal</SO>
<YR>1959</YR>
<VL>1</VL>
<NO>5130</NO>
<PG>1162-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Romney-1981" MODIFIED="2013-02-09 15:22:33 +0000" MODIFIED_BY="Heather Maxwell" NAME="Romney 1981" YEAR="1981">
<REFERENCE MODIFIED="2013-02-09 15:22:33 +0000" MODIFIED_BY="Heather Maxwell" NOTES="&lt;p&gt;[1934]&lt;/p&gt;" NOTES_MODIFIED="2013-02-09 15:22:33 +0000" NOTES_MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Romney ML, Gordon H</AU>
<TI>Is your enema really necessary?</TI>
<SO>British Medical Journal</SO>
<YR>1981</YR>
<VL>282</VL>
<NO>6272</NO>
<PG>1269-71</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1981185288"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rosenfield-1958" NAME="Rosenfield 1958" YEAR="1958">
<REFERENCE NOTES="&lt;p&gt;[141]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rosenfield HH, Burke L, Rubin H</AU>
<TI>Disposable enema unit in obstetrics</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1958</YR>
<VL>11</VL>
<NO>2</NO>
<PG>222-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rutgers-1993" MODIFIED="2013-02-09 15:23:32 +0000" MODIFIED_BY="Heather Maxwell" NAME="Rutgers 1993" YEAR="1993">
<REFERENCE MODIFIED="2013-02-09 15:23:32 +0000" MODIFIED_BY="Heather Maxwell" NOTES="&lt;p&gt;[8551]&lt;/p&gt;" NOTES_MODIFIED="2013-02-09 15:23:32 +0000" NOTES_MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rutgers S</AU>
<TI>Hot, high and horrible. Should routine enemas still be given to women in labour?</TI>
<SO>Central African Journal of Medicine</SO>
<YR>1993</YR>
<VL>39</VL>
<NO>6</NO>
<PG>117-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tzeng-2005" NAME="Tzeng 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tzeng YL, Shih YJ, Teng YK, Chiu CY, Huang MY</AU>
<TI>Enema prior to labor: a controversial routine in Taiwan</TI>
<SO>Journal of Nursing Research</SO>
<YR>2005</YR>
<VL>13</VL>
<NO>4</NO>
<PG>263-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Whitley-1980" NAME="Whitley 1980" YEAR="1980">
<REFERENCE NOTES="&lt;p&gt;[1425]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Whitley N, Mack E</AU>
<TI>Are enemas justified for women in labor?</TI>
<SO>American Journal of Nursing</SO>
<YR>1980</YR>
<VL>80</VL>
<NO>7</NO>
<PG>1339</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2010-02-17 02:05:21 +0000" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-07-04 11:02:06 +0100" MODIFIED_BY="Denise Atherton">
<ADDITIONAL_REFERENCES MODIFIED="2013-07-04 11:02:06 +0100" MODIFIED_BY="Lynn Hampson">
<REFERENCE ID="REF-Chalmers-2009" MODIFIED="2010-03-11 11:20:08 +0000" MODIFIED_BY="Jill V Hampson" NAME="Chalmers 2009" TYPE="JOURNAL_ARTICLE">
<AU>Chalmers B, Kaczorowski J, Levitt C, Dzakpasu S, O'Brien B, Lee L, et al</AU>
<TI>Use of routine interventions in vaginal labor and birth: findings from the Maternity Experiences Survey</TI>
<SO>Birth</SO>
<YR>2009</YR>
<VL>36</VL>
<NO>1</NO>
<PG>13-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Conde_x002d_Agudelo-2008" MODIFIED="2013-02-09 15:24:53 +0000" MODIFIED_BY="[Empty name]" NAME="Conde-Agudelo 2008" TYPE="JOURNAL_ARTICLE">
<AU>Conde-Agudelo A, Rosas-Bermudez A, Gülmezoglu AM</AU>
<TI>Evidence-based intrapartum care in Cali, Colombia: a quantitative and qualitative study</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2008</YR>
<VL>115</VL>
<NO>12</NO>
<PG>1547-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Curtis-2007" MODIFIED="2010-03-11 11:20:22 +0000" MODIFIED_BY="Jill V Hampson" NAME="Curtis 2007" TYPE="OTHER">
<AU>Curtis GB</AU>
<TI>Your pregnancy week by week</TI>
<SO>http://www.mdadvice.com/library/urpreg/wbw37.htm</SO>
<YR>(accessed March 12 2007)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gayer-2002" NAME="Gayer 2002" TYPE="JOURNAL_ARTICLE">
<AU>Gayer G, Zissin R, Apter S, Oscadchy A, Hertz M</AU>
<TI>Perforations of the rectosigmoid colon induced by cleansing enema: CT findings in 14 patients</TI>
<SO>Abdominal Imaging</SO>
<YR>2002</YR>
<VL>27</VL>
<NO>4</NO>
<PG>453-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-07-02 14:33:42 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Levitt-2011" MODIFIED="2013-02-09 15:25:55 +0000" MODIFIED_BY="[Empty name]" NAME="Levitt 2011" TYPE="JOURNAL_ARTICLE">
<AU>Levitt C, Hanvey L, Bartholomew S, Kaczorowski J, Chalmers B, Heaman M, et al</AU>
<TI>Use of routine interventions in labour and birth in Canadian hospitals: comparing results of the 1993 and 2007 Canadian hospital maternity policies and practices surveys</TI>
<SO>Journal of Obstetrics and Gynaecology Canada</SO>
<YR>2011</YR>
<VL>33</VL>
<NO>12</NO>
<PG>1208-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Paran-1999" NAME="Paran 1999" TYPE="JOURNAL_ARTICLE">
<AU>Paran H, Butnaru G, Neufeld D, Magen A, Freund U</AU>
<TI>Enema-induced perforation of the rectum in chronically constipated patients</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>1999</YR>
<VL>42</VL>
<NO>12</NO>
<PG>1609-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-PregnancyWeekly.com" MODIFIED="2010-03-11 11:20:29 +0000" MODIFIED_BY="Jill V Hampson" NAME="PregnancyWeekly.com" TYPE="OTHER">
<AU>PregnancyWeekly.com</AU>
<TI>Enema</TI>
<SO>http://www.pregnancyweekly.com/pregnancy_information/enema.htm</SO>
<YR>(accessed March 12 2007)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2012" MODIFIED="2013-07-04 11:02:06 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2012" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2012</YR>
<EN>5.2</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-SEA_x002d_ORCHID-Study-Group-2008" MODIFIED="2012-05-18 19:43:05 +0100" MODIFIED_BY="[Empty name]" NAME="SEA-ORCHID Study Group 2008" TYPE="JOURNAL_ARTICLE">
<AU>SEA-ORCHID Study Group, Laopaiboon M, Lumbiganon P, McDonald SJ, Henderson-Smart DJ, Green S, Crowther CA</AU>
<TI>Use of evidence-based practices in pregnancy and childbirth: South East Asia Optimising Reproductive and Child Health in Developing Countries project</TI>
<SO>PLoS One</SO>
<YR>2008</YR>
<VL>3</VL>
<NO>7</NO>
<PG>e2646</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sodr_x00e9_-2007" MODIFIED="2013-02-09 15:27:34 +0000" MODIFIED_BY="[Empty name]" NAME="Sodré 2007" TYPE="JOURNAL_ARTICLE">
<AU>Sodré TM, Lacerda RA</AU>
<TI>The working process in labor care in Londrina-PR</TI>
<SO>Revista da Escola de Enfermagem da USP</SO>
<YR>2007</YR>
<VL>41</VL>
<NO>1</NO>
<PG>82-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sweidan-2008" MODIFIED="2013-02-09 15:28:48 +0000" MODIFIED_BY="[Empty name]" NAME="Sweidan 2008" TYPE="JOURNAL_ARTICLE">
<AU>Sweidan M, Mahfoud Z, DeJong J</AU>
<TI>Hospital policies and practices concerning normal childbirth in Jordan</TI>
<SO>Studies in Family Planning</SO>
<YR>2008</YR>
<VL>39</VL>
<NO>1</NO>
<PG>59-68</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yeat-2011" MODIFIED="2013-02-09 15:31:03 +0000" MODIFIED_BY="[Empty name]" NAME="Yeat 2011" TYPE="JOURNAL_ARTICLE">
<AU>Yeat SK, Chen SC, Lee HH</AU>
<TI>Enema resulting in rectal prolapse and colostomy in a term pregnant woman</TI>
<SO>Taiwanese Journal of Obstetrics and Gynecology</SO>
<YR>2011</YR>
<VL>50</VL>
<NO>3</NO>
<PG>370-1</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2013-02-09 15:56:52 +0000" MODIFIED_BY="Denise Atherton">
<REFERENCE ID="REF-Cuervo-1999" MODIFIED="2012-03-01 10:52:58 +0000" MODIFIED_BY="Jill V Hampson" NAME="Cuervo 1999" TYPE="COCHRANE_REVIEW">
<AU>Cuervo LG, Rodríguez MN, Delgado MB</AU>
<TI>Enemas during labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1999</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2012-03-01 10:52:58 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-03-01 10:52:58 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000330"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hay_x002d_Smith-1995a" NAME="Hay-Smith 1995a" TYPE="OTHER">
<AU>Hay-Smith J</AU>
<TI>Routine enema on admission in labour. [revised 27 January 1994]</TI>
<SO>In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hay_x002d_Smith-1995b" NAME="Hay-Smith 1995b" TYPE="OTHER">
<AU>Hay-Smith J</AU>
<TI>Soapsuds vs tapwater enema on admission in labour. [revised 26 January 1994]</TI>
<SO>In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hay_x002d_Smith-1995c" MODIFIED="2010-05-20 14:52:34 +0100" MODIFIED_BY="Denise Atherton" NAME="Hay-Smith 1995c" TYPE="OTHER">
<AU>Hay-Smith J</AU>
<TI>`Medicated' vs soapsuds enema on admission in labour. [revised 26 January 1994]</TI>
<SO>In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hay_x002d_Smith-1995d" NAME="Hay-Smith 1995d" TYPE="OTHER">
<AU>Hay-Smith J</AU>
<TI>`Medicated' vs tapwater enema on admission in labour. [revised 27 January 1994]</TI>
<SO>In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reveiz-2007" MODIFIED="2013-02-09 15:56:52 +0000" MODIFIED_BY="Heather Maxwell" NAME="Reveiz 2007" TYPE="COCHRANE_REVIEW">
<AU>Reveiz L, Gaitán HG, Cuervo LG</AU>
<TI>Enemas during labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2013-02-09 15:56:45 +0000" MODIFIED_BY="Heather Maxwell">
<IDENTIFIER MODIFIED="2013-02-09 15:56:45 +0000" MODIFIED_BY="Heather Maxwell" TYPE="DOI" VALUE="10.1002/14651858.CD000330.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-02-10 16:04:27 +0000" MODIFIED_BY="Denise Atherton">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-02-10 16:04:27 +0000" MODIFIED_BY="Denise Atherton" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-02-09 17:18:01 +0000" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Clarke-2007">
<CHAR_METHODS MODIFIED="2013-02-09 17:17:51 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised clinical trial. Randomisation method was not explained.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-02-17 02:22:21 +0000" MODIFIED_BY="[Empty name]">
<P>152 pregnant women admitted for delivery. The characteristics of participating women are not described.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-02-09 17:18:01 +0000" MODIFIED_BY="[Empty name]">
<P>Women were randomly allocated to receive either standardised enema soap solution within 30 minutes of enrolment or no enema (75 women to enema and 77 to no enema).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-05-20 14:44:37 +0100" MODIFIED_BY="Denise Atherton">
<P>The primary outcome was time interval from enrolment to delivery. Secondary outcomes included intrapartum infection rate, faecal soiling at delivery, mode of delivery and patient satisfaction.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-04-13 12:26:27 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract publication.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-02-09 17:19:48 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cuervo-2006">
<CHAR_METHODS MODIFIED="2013-02-09 17:18:42 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised clinical trial. Block randomisations in blocks of 2 (20%), 4 (60%) and 6 (20%) using sealed envelopes when participants visited the obstetrics admission ward and filled inclusion criteria.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Women attending a tertiary care hospital in Bogota, Colombia for delivery. Inclusion criteria included: living and staying in Bogota the month following delivery; gestational age of 36 or more weeks; willingness to participate. Exclusion criteria: medical emergency; use of antibiotics the week prior to admission; rupture of amniotic membranes; cervical dilatation over 7 cm.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-02-09 17:18:55 +0000" MODIFIED_BY="Heather Maxwell">
<P>High volume (1000 mL) saline solution enema or no enema.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-02-09 17:19:48 +0000" MODIFIED_BY="[Empty name]">
<P>Participants and newborns were followed for 1 month after delivery. Visits were carried out at the puerperium and paediatrics ward and neonatal intensive care unit. Participants were evaluated through telephone interviews and/or physical examination carried out 1 and 4 weeks after delivery. 24-hour pager service was offered to inform of any health problems. Telephone follow-up was performed when patients failed to attend programmed visits. Infections were diagnosed on clinical grounds. Neonatal infections included: ocular, umbilical or skin infection; lower or upper respiratory tract infection; intestinal infection; meningitis or sepsis. Puerperal infections included: dehiscence of the episiorraphy suture; purulent effusion from episiorraphy; urinary tract infection; pelvic inflammatory disease or vulvovaginitis.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Blinding was not possible although an effort was made to keep the hypothesis unknown to staff and participants.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-02-09 17:25:16 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Drayton-1984">
<CHAR_METHODS MODIFIED="2013-02-09 17:24:35 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised clinical trial, with stratified allocation (primigravid vs multigravid). Randomisation method was not explained.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-02-09 17:24:27 +0000" MODIFIED_BY="[Empty name]">
<P>Women entering labour ward during the first stage of labour, for vaginal delivery, single pregnancy and 37 or more weeks of gestation. Exclusion criteria included diabetes, cardiac disease or pregnancy complicated by antepartum haemorrhage or severe pre-eclampsia. 370 women were eligible and 222 (60%) agreed to participate.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Low-volume disposable phosphate enema in the study group vs no enema. Inclusion bias could have occurred when the clinic staff avoided the inclusion of women who had faecal deposition prior to admission.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-02-09 17:25:11 +0000" MODIFIED_BY="[Empty name]">
<P>Faecal contamination was evaluated with an arbitrary scale, not validated, previously described by Romney and Gordon (<LINK REF="STD-Romney-1981" TYPE="STUDY">Romney 1981</LINK>).<BR/>Infection evaluation is not clear. Follow-up time is not clearly discussed, but there are no data suggesting that women were followed up after leaving the hospital. Infections were confirmed bacteriologically and association between the organism and soiling was established by a microbiologist and a research sister.<BR/>Duration of labour: it was stratified between primigravidae and multigravidae. Data were collected in 6 ordinal and arbitrary categories. No clear time of follow-up.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-02-09 17:25:16 +0000" MODIFIED_BY="Heather Maxwell">
<P>Stratification would be better done by parity instead of gravidity. Randomisation method was not discussed in the article.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-02-09 17:26:19 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kovavisarach-2005">
<CHAR_METHODS MODIFIED="2013-02-09 17:26:00 +0000" MODIFIED_BY="Heather Maxwell">
<P>Randomised clinical trial. Randomisation method not explained.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-02-09 17:26:05 +0000" MODIFIED_BY="[Empty name]">
<P>1027 pregnant women with labour pain were randomised to receive enema vs no enema.<BR/>Inclusion criteria: all were in the gestational age range of 37-42 weeks and met the inclusion criteria consisting of living singleton pregnancy, vertex presentation, having normal bowel function, and with true labour.<BR/>Exclusion criteria: the pregnancies with medical or obstetric complications such as history of premature rupture of membranes, unexplained vaginal bleeding, previous uterine scar or previous antibiotics usage within 7 days before admission were excluded from the present study.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-02-09 17:26:19 +0000" MODIFIED_BY="[Empty name]">
<P>Experiment group: the enema in the present study (Uni-ma enema) consisted of sodium biphosphate and sodium phosphate 118 mL.<BR/>Control group: no enema.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Faecal contamination rate during the second stage of labour with an arbitrary scale; neonatal infection; duration of labour; route of delivery; degree of perineal tear; and satisfactory level of parturients and medical staff using the Likert scale. Women and babies were followed up for 4 days.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>cm: centimetre<BR/>mL: millilitre<BR/>vs: versus</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-02-09 17:17:20 +0000" MODIFIED_BY="Denise Atherton" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2013-02-09 17:16:28 +0000" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Lopes-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-02-09 17:16:28 +0000" MODIFIED_BY="Denise Atherton">
<P>Inadequate randomisation by hospital file number. 90 pregnant women (43 normal births, 27 forceps and 20 caesarean sections) were included in the study. Enema group did not provide faster labour and did not reduce faecal contamination.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-02 16:55:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lurie-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-02 16:55:46 +0100" MODIFIED_BY="[Empty name]">
<P>Enemas given before cesarean section.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-02-09 17:16:24 +0000" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Mathie-1959">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-02-09 17:16:24 +0000" MODIFIED_BY="Denise Atherton">
<P>This is a trial that used for controls women receiving other interventions such as oral administration of castor oil and hot baths. It evaluated outcomes through physiologic measurements with a tocodynamometer. The studies were performed before labour. Neonatal or maternal morbidity or mortality was not evaluated. Labour duration was not evaluated either. It does not comply with inclusion criteria for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-02-09 17:17:03 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Romney-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-02-09 17:17:03 +0000" MODIFIED_BY="[Empty name]">
<P>This was not a randomised controlled trial. A pilot study was done with a population of 84 consecutively admitted women who had no enema and compared them with 111 women admitted for induction of labour who received an enema. Later, they recruited 50 women with a haphazard allocation of enema vs no enema. The authors grouped the populations studied in the pilot and the main study together. No information regarding sample size selection is described. There is no description of the methodology of statistical analysis.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-02-09 17:17:10 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Rosenfield-1958">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-02-09 17:17:10 +0000" MODIFIED_BY="Heather Maxwell">
<P>This is not a randomised controlled trial. There was no information about the characteristics of the included women.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rutgers-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>This was a case-control study as described in the abstract. Sample size is not adjusted and its calculation is not based on risk analysis for case-control studies.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-02-09 17:17:20 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Tzeng-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-02-09 17:17:20 +0000" MODIFIED_BY="Heather Maxwell">
<P>This is not a randomised controlled trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Whitley-1980">
<CHAR_REASON_FOR_EXCLUSION>
<P>Observational study. Contamination was the main outcome and was measured according to the opinion of researchers. Labour duration, morbidity and mortality were not assessed.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>vs: versus</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2010-02-17 02:05:21 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-02-10 16:04:27 +0000" MODIFIED_BY="Denise Atherton">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2013-02-09 17:20:12 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-17 02:37:09 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Clarke-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-09 17:20:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cuervo-2006">
<DESCRIPTION>
<P>Randomisation was done in blocks of 2 (20%), 4 (60%) and 6 (20%) using Ralloc® allocation software.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-17 02:41:36 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Drayton-1984">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-17 02:40:05 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kovavisarach-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-02-09 17:20:16 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-17 02:37:12 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Clarke-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-02-09 17:20:16 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cuervo-2006">
<DESCRIPTION>
<P>Opaque envelope with sequential numbering and instructions was opened.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-17 02:41:37 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Drayton-1984">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-17 02:40:05 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kovavisarach-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2012-06-25 14:17:58 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-04-13 12:26:41 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Clarke-2007">
<DESCRIPTION>
<P>Not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-04-13 12:27:43 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cuervo-2006">
<DESCRIPTION>
<P>Not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-04-13 12:28:42 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Drayton-1984">
<DESCRIPTION>
<P>Not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-06-25 14:17:58 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kovavisarach-2005">
<DESCRIPTION>
<P>Not done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2013-02-10 16:04:27 +0000" MODIFIED_BY="Denise Atherton" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-05-20 14:44:37 +0100" MODIFIED_BY="Denise Atherton" RESULT="UNKNOWN" STUDY_ID="STD-Clarke-2007">
<DESCRIPTION>
<P>There are some missing data in outcomes' results. Women's satisfaction and neonatal outcomes were not reported. No standard deviation was provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-02-10 16:04:27 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cuervo-2006">
<DESCRIPTION>
<P>There were 12 protocol violations; women who did not fulfil the inclusion criteria were identified and excluded from the final analysis (4 allocated to enema, 8 to no enema). The remaining women were analysed by intention-to-treat; losses to follow-up were 35/217 (16%) in the enema group and 24/214 (11%) in the control group (P = 0.14). Losses to follow-up among newborns were 18% in the enema group and 11% in the control group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-11 20:48:13 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Drayton-1984">
<DESCRIPTION>
<P>There are some missing data in outcomes' results. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-04-13 12:29:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kovavisarach-2005">
<DESCRIPTION>
<P>There are no missing data in outcomes' results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2013-01-11 20:48:32 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-17 02:34:16 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Clarke-2007">
<DESCRIPTION>
<P>Protocol of the study is not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-17 02:34:35 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cuervo-2006">
<DESCRIPTION>
<P>Protocol of the study is not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-11 20:48:32 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Drayton-1984">
<DESCRIPTION>
<P>Protocol of the study is not available. In the <LINK REF="STD-Drayton-1984" TYPE="STUDY">Drayton 1984</LINK> study the means to assess infection as well as the time of follow-up was not reported by the authors. Infection rates were remarkably low in newborns and puerperal women as compared to the study from Colombia (<LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>). </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-02-17 02:40:05 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kovavisarach-2005">
<DESCRIPTION>
<P>Protocol of the study is not available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2013-01-11 20:48:01 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-25 15:09:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Clarke-2007">
<DESCRIPTION>
<P>Declarations of interest are not declared. No information was provided concerning baseline demographics</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-25 15:10:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cuervo-2006">
<DESCRIPTION>
<P>Information was provided concerning baseline demographics. Declarations of interest are declared.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-11 20:48:01 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Drayton-1984">
<DESCRIPTION>
<P>Inclusion bias seemed to happen when clinic staff excluded women if they had faecal soiling prior to their evaluation (time span unspecified). The authors provide no demographic data that would be relevant to know the external validity of the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-25 15:12:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kovavisarach-2005">
<DESCRIPTION>
<P>Information was provided concerning baseline demographics. Declarations of interest are not declared.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2013-02-13 12:22:20 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2013-02-13 12:22:20 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2013-01-11 21:30:28 +0000" MODIFIED_BY="[Empty name]">Findings of individual studies</TITLE>
<TABLE COLS="2" ROWS="5">
<TR>
<TD>
<P>
<B>Study ID</B>
</P>
</TD>
<TD>
<P>
<B>Comments</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Drayton-1984" TYPE="STUDY">Drayton 1984</LINK>
</P>
</TD>
<TD>
<P>The RCT from Wales investigated the incidence of maternal and neonatal infections. None of the women had a perineal wound infection. Regarding neonatal infections, no significant differences were found between the enema and the no-enema groups (one RCT; 222 women; risk ratio (RR) 0.89, 95% confidence interval (CI) 0.31 to 2.56; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). The RCT also evaluated women's views on enemas. In the no-enema group, 14.1% of women willingly accepted to receive a future enema compared to 39.6% in the enema group (P &lt; 0.01).</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>
</P>
</TD>
<TD>
<P>In the trial from Thailand, the duration of labour was shorter in the enema group (1027 women; 409.4 minutes versus 459.8 minutes; mean difference (MD) -50.40, 95% CI -75.68 to -25.12; P &lt; 0.001; <LINK REF="CMP-001.21" TYPE="ANALYSIS">Analysis 1.21</LINK>) but no adjustment was done by parity. No significant differences were found in the route of delivery, degree of perineal tear and perineal wound infection rates. No neonatal infections occurred during the four-day follow-up, which seems a short time to identify infections comprehensively. No significant differences were found with regard to satisfaction between women receiving an enema versus those not receiving an enema, as assessed using a five-point Likert scale (1027 women; 3.58 versus 3.58; MD 0.00, CI 95% -0.10 to 0.10; P = 0.922; <LINK REF="CMP-001.23" TYPE="ANALYSIS">Analysis 1.23</LINK>). Satisfaction levels of labour attendants and healthcare providers were significantly higher in the enema group (P &lt; 0.01) than in the control group (measured using the Likert scale).</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Cuervo-2006" TYPE="STUDY">Cuervo 2006</LINK>
</P>
</TD>
<TD>
<P>The trial from Colombia investigated the effect of enemas on labour duration adjusted by parity. It found no statistically significant differences between groups for delivery types, episiotomy rates, or prescription of antibiotics. No significant differences were found in lower and upper respiratory tract infections rates. Similarly, no significant differences were found for ophthalmic infection rates, skin infections, or intestinal infections. The authors reported no significant differences in the distribution between groups for newborns' "Ballard" score, birthweight, diagnosis of neonatal apnoea, or the administration of ocular and umbilical prophylaxis. Twelve per cent of women had caesarean sections with no significant differences in rates between groups. In addition, no significant differences were found for the duration of labour (for all women for first stage of labour: median 515 minutes with enemas versus 585 minutes without enemas, P = 0.24; for second stage of labour: mean 43.2 minutes with enemas and 38 minutes without; MD 5.20, 95% CI -2.56 to 12.96; P=0.19; <LINK REF="CMP-001.22" TYPE="ANALYSIS">Analysis 1.22</LINK>). These results could not be aggregated with the RCT from Thailand (<LINK REF="STD-Kovavisarach-2005" TYPE="STUDY">Kovavisarach 2005</LINK>) as times did not follow a normal distribution and, therefore, trialists considered non-parametric measures (differences between medians). Finally, there were no significant difference in the degree of perineal tear between groups. The Colombian RCT found no significant differences between groups in the rate of neonatal infection after one month of follow-up (370 newborns; RR 1.12, 95% CI 0.76 to 1.67; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Clarke-2007" TYPE="STUDY">Clarke 2007</LINK>
</P>
</TD>
<TD>
<P>In the trial from the United States, the mean times to delivery were 504.7 minutes and 392.7 minutes for enema and no enema respectively (152 women; MD 112, 95% CI 48.13 to 175.87; <LINK REF="CMP-001.21" TYPE="ANALYSIS">Analysis 1.21</LINK>); we estimated the standard deviations because these were not provided by the researchers. Intrapartum infection rates were significantly higher in the enema group (RR 4.62, 95% CI 1.03 to 20.68; <LINK REF="CMP-001.33" TYPE="ANALYSIS">Analysis 1.33</LINK>). However, when controlling for duration of membrane rupture, enema use fell below the level of significance for infection (no data was provided by trialists). Women who received enemas had significantly less faecal soiling at delivery (RR 0.36, 95% CI 0.17 to 0.75; <LINK REF="CMP-001.20" TYPE="ANALYSIS">Analysis 1.20</LINK>). There was no significant difference in the mode of delivery between the two groups. No neonatal outcomes were reported.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>RCT: randomised controlled trial</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-01-31 15:48:23 +0000" MODIFIED_BY="Denise Atherton">
<COMPARISON ID="CMP-001" MODIFIED="2013-01-31 15:48:23 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Enema versus no enema</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.142613764828112" CI_START="0.41077462434158596" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6850961538461539" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="32" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.057899451610479345" LOG_CI_START="-0.3863963928469444" LOG_EFFECT_SIZE="-0.16424847061823253" METHOD="MH" MODIFIED="2013-01-31 15:16:27 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.14730144688377572" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="182" TOTAL_2="190" WEIGHT="100.0" Z="1.4491294075489394">
<NAME>Episiotomy dehiscence</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.142613764828112" CI_START="0.41077462434158596" EFFECT_SIZE="0.6850961538461539" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="32" LOG_CI_END="0.057899451610479345" LOG_CI_START="-0.3863963928469444" LOG_EFFECT_SIZE="-0.16424847061823253" MODIFIED="2013-01-21 10:31:46 +0000" MODIFIED_BY="[Empty name]" ORDER="52539" O_E="0.0" SE="0.2609815783341906" STUDY_ID="STD-Cuervo-2006" TOTAL_1="182" TOTAL_2="190" VAR="0.06811138422980528" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.5602072335741908" CI_START="0.3084147865230059" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8885976408912188" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" I2="0.0" I2_Q="100.0" ID="CMP-001.02" LOG_CI_END="0.4082751202943257" LOG_CI_START="-0.51086480846996" LOG_EFFECT_SIZE="-0.05129484408781713" METHOD="MH" MODIFIED="2013-01-31 15:17:12 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.8268361235085789" Q="6.606965146857953E-34" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="109" TOTAL_2="113" WEIGHT="100.0" Z="0.21876113496642896">
<NAME>Neonatal infection (all infections, including umbilical)</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.5602072335741908" CI_START="0.3084147865230059" EFFECT_SIZE="0.8885976408912188" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.4082751202943257" LOG_CI_START="-0.51086480846996" LOG_EFFECT_SIZE="-0.05129484408781713" ORDER="52516" O_E="0.0" SE="0.5399073439721672" STUDY_ID="STD-Drayton-1984" TOTAL_1="109" TOTAL_2="113" VAR="0.2914999400750801" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-01-31 15:17:40 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="500" TOTAL_2="527" WEIGHT="0.0" Z="0.0">
<NAME>Neonatal infection (not specified) at 4 days</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favorus no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="52519" O_E="0.0" SE="0.0" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="500" TOTAL_2="527" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.6662654586934107" CI_START="0.7571279352768765" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1231990591002645" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="38" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.22174419158566833" LOG_CI_START="-0.12083072962769519" LOG_EFFECT_SIZE="0.05045673097898656" METHOD="MH" MODIFIED="2013-01-31 15:18:26 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.5637008377314057" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="179" TOTAL_2="191" WEIGHT="100.0" Z="0.5773532700302194">
<NAME>Neonatal Infection (any infectious outcome, during the first month of life)</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.6662654586934107" CI_START="0.7571279352768765" EFFECT_SIZE="1.1231990591002645" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="38" LOG_CI_END="0.22174419158566833" LOG_CI_START="-0.12083072962769519" LOG_EFFECT_SIZE="0.05045673097898656" ORDER="52520" O_E="0.0" SE="0.2012302044939388" STUDY_ID="STD-Cuervo-2006" TOTAL_1="179" TOTAL_2="191" VAR="0.04049359520067242" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.9516583449153992" CI_END="19.81760437230664" CI_START="0.5036198341508952" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="3.1591990483743064" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="1.2970511541467526" LOG_CI_START="-0.29789717432933754" LOG_EFFECT_SIZE="0.4995769899087075" METHOD="MH" MODIFIED="2013-01-31 15:19:15 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.3292977174352041" P_Q="1.0" P_Z="0.21951542645095978" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="288" TOTAL_2="304" WEIGHT="100.0" Z="1.2278177170310445">
<NAME>Neonatal infection: umbilical infection</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="143.54525230344842" CI_START="0.388387008392696" EFFECT_SIZE="7.466666666666667" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.156988832969676" LOG_CI_START="-0.4107353057406756" LOG_EFFECT_SIZE="0.8731267636145004" ORDER="52517" O_E="0.0" SE="1.5082938695179386" STUDY_ID="STD-Cuervo-2006" TOTAL_1="179" TOTAL_2="191" VAR="2.2749503968253966" WEIGHT="33.00951625693894"/>
<DICH_DATA CI_END="16.368023482011694" CI_START="0.06566102404381331" EFFECT_SIZE="1.036697247706422" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2139962394192083" LOG_CI_START="-1.182692348333616" LOG_EFFECT_SIZE="0.01565194554279609" ORDER="52518" O_E="0.0" SE="1.4078267402458553" STUDY_ID="STD-Drayton-1984" TOTAL_1="109" TOTAL_2="113" VAR="1.9819761305512706" WEIGHT="66.99048374306106"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.518375442583428" CI_START="0.7327996232278564" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.819632881085395" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.6549823146471708" LOG_CI_START="-0.13501476263456325" LOG_EFFECT_SIZE="0.2599837760063038" METHOD="MH" MODIFIED="2013-01-31 15:19:47 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.19704123299560797" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="179" TOTAL_2="190" WEIGHT="100.0" Z="1.2900271461519899">
<NAME>Neonatal infection: respiratory tract infection (high - during first month)</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.518375442583428" CI_START="0.7327996232278564" EFFECT_SIZE="1.819632881085395" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" LOG_CI_END="0.6549823146471708" LOG_CI_START="-0.13501476263456325" LOG_EFFECT_SIZE="0.2599837760063038" ORDER="52523" O_E="0.0" SE="0.4640481937438916" STUDY_ID="STD-Cuervo-2006" TOTAL_1="179" TOTAL_2="190" VAR="0.2153407261169684" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.7320604227090253" CI_START="0.005372461546690787" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.09646464646464646" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.2385630382537266" LOG_CI_START="-2.269826684281334" LOG_EFFECT_SIZE="-1.0156318230138035" METHOD="MH" MODIFIED="2013-01-31 15:20:10 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.11247751672529947" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="179" TOTAL_2="190" WEIGHT="100.0" Z="1.5871551192994418">
<NAME>Neonatal infection: respiratory tract infection (low - during first month)</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.7320604227090253" CI_START="0.005372461546690787" EFFECT_SIZE="0.09646464646464646" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2385630382537266" LOG_CI_START="-2.269826684281334" LOG_EFFECT_SIZE="-1.0156318230138035" ORDER="52524" O_E="0.0" SE="1.4734405397464756" STUDY_ID="STD-Cuervo-2006" TOTAL_1="179" TOTAL_2="190" VAR="2.171027024168385" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-01-31 15:21:13 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="179" TOTAL_2="191" WEIGHT="0.0" Z="0.0">
<NAME>Neonatal infection: meningitis</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="52527" O_E="0.0" SE="0.0" STUDY_ID="STD-Cuervo-2006" TOTAL_1="179" TOTAL_2="191" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-01-31 15:28:24 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="179" TOTAL_2="191" WEIGHT="0.0" Z="0.0">
<NAME>Neontal infection: sepsis</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="52528" O_E="0.0" SE="0.0" STUDY_ID="STD-Cuervo-2006" TOTAL_1="179" TOTAL_2="191" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.01636671344510368" CI_END="1.711043774419379" CI_START="0.7552056668607857" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.136745334139702" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="40" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.2332611204385867" LOG_CI_START="-0.12193475986844181" LOG_EFFECT_SIZE="0.05566318028507244" METHOD="MH" MODIFIED="2013-01-31 15:28:58 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.8982024296853277" P_Q="1.0" P_Z="0.5390192859840764" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="713" TOTAL_2="735" WEIGHT="100.0" Z="0.6142967003412241">
<NAME>Perineal tear: skin or superficial tissue without compromising muscle</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9045266006212294" CI_START="0.6465692940887178" EFFECT_SIZE="1.1096884336320956" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="22" LOG_CI_END="0.2797870428527474" LOG_CI_START="-0.1893849241050371" LOG_EFFECT_SIZE="0.045201059373855185" MODIFIED="2013-01-21 10:25:44 +0000" MODIFIED_BY="[Empty name]" ORDER="52531" O_E="0.0" SE="0.2755939358296949" STUDY_ID="STD-Cuervo-2006" TOTAL_1="213" TOTAL_2="208" VAR="0.07595201746610197" WEIGHT="55.949656351515465"/>
<DICH_DATA CI_END="2.1877312433528213" CI_START="0.6269057219597041" EFFECT_SIZE="1.1711111111111112" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="18" LOG_CI_END="0.3399939690791791" LOG_CI_START="-0.2027977662047732" LOG_EFFECT_SIZE="0.06859810143720296" MODIFIED="2013-01-21 10:25:44 +0000" MODIFIED_BY="[Empty name]" ORDER="52532" O_E="0.0" SE="0.3188385521682164" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="500" TOTAL_2="527" VAR="0.10165802234872444" WEIGHT="44.050343648484535"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.396879430665504" CI_START="0.3706443721320402" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7195453422288115" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.14515892232292293" LOG_CI_START="-0.4310425898240571" LOG_EFFECT_SIZE="-0.1429418337505671" METHOD="MH" MODIFIED="2013-01-31 15:30:19 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="0.33083145957276616" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="213" TOTAL_2="208" WEIGHT="100.0" Z="0.9724405095409012">
<NAME>Perineal tear: perineal muscle without anal muscles</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.396879430665504" CI_START="0.3706443721320402" EFFECT_SIZE="0.7195453422288115" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" LOG_CI_END="0.14515892232292293" LOG_CI_START="-0.4310425898240571" LOG_EFFECT_SIZE="-0.1429418337505671" MODIFIED="2013-01-21 10:28:49 +0000" MODIFIED_BY="[Empty name]" ORDER="52533" O_E="0.0" SE="0.33846362047862155" STUDY_ID="STD-Cuervo-2006" TOTAL_1="213" TOTAL_2="208" VAR="0.11455762238749637" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3637281037578223" CI_END="1.64358513876266" CI_START="0.13101987009647215" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4640499018135613" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-001.12" LOG_CI_END="0.21579220573259958" LOG_CI_START="-0.882662835497983" LOG_EFFECT_SIZE="-0.3334353148826917" METHOD="MH" MODIFIED="2013-01-31 15:30:42 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.5464432498732054" P_Q="1.0" P_Z="0.2340890253102791" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="713" TOTAL_2="735" WEIGHT="100.0" Z="1.1898915910326529">
<NAME>Perineal tear: compromises anal muscles but not the mucosa</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.4204824849297983" CI_START="0.14182997275350073" EFFECT_SIZE="0.5859154929577465" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.3839019443510624" LOG_CI_START="-0.8482319805357275" LOG_EFFECT_SIZE="-0.23216501809233253" MODIFIED="2013-01-21 10:29:10 +0000" MODIFIED_BY="[Empty name]" ORDER="52534" O_E="0.0" SE="0.7237615666397946" STUDY_ID="STD-Cuervo-2006" TOTAL_1="213" TOTAL_2="208" VAR="0.5238308053448899" WEIGHT="67.51438142543607"/>
<DICH_DATA CI_END="4.379583965376982" CI_START="0.010144240282339605" EFFECT_SIZE="0.21077844311377245" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6414328570514453" LOG_CI_START="-1.9937804723903498" LOG_EFFECT_SIZE="-0.6761738076694522" MODIFIED="2013-01-21 10:29:10 +0000" MODIFIED_BY="[Empty name]" ORDER="52535" O_E="0.0" SE="1.5479373542304704" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="500" TOTAL_2="527" VAR="2.3961100526220287" WEIGHT="32.48561857456394"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="71.51431497617533" CI_START="0.1200368394501551" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.9299065420560746" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="1.8543929829605488" LOG_CI_START="-0.9206854479974977" LOG_EFFECT_SIZE="0.4668537674815256" METHOD="MH" MODIFIED="2013-01-31 15:31:04 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Q="1.0" P_Z="0.5096050735847617" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="213" TOTAL_2="208" WEIGHT="100.0" Z="0.6594527636429602">
<NAME>Perineal tear: complete tear that compromises anal mucosa</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="71.51431497617533" CI_START="0.1200368394501551" EFFECT_SIZE="2.9299065420560746" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8543929829605488" LOG_CI_START="-0.9206854479974977" LOG_EFFECT_SIZE="0.4668537674815256" MODIFIED="2013-01-21 10:29:25 +0000" MODIFIED_BY="[Empty name]" ORDER="52536" O_E="0.0" SE="1.630094807204535" STUDY_ID="STD-Cuervo-2006" TOTAL_1="213" TOTAL_2="208" VAR="2.6572090804751896" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.2712225892957445" CI_START="0.42820891052728105" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7378" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="30" I2="0.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="0.1042216015682086" LOG_CI_START="-0.36834429978663935" LOG_EFFECT_SIZE="-0.13206134910921535" METHOD="MH" MODIFIED="2013-01-31 15:32:06 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="1.0" P_Q="1.0" P_Z="0.27332079860831926" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="500" TOTAL_2="527" WEIGHT="100.0" Z="1.0954471630803266">
<NAME>No episiotomy wound - no further tear</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2712225892957445" CI_START="0.42820891052728105" EFFECT_SIZE="0.7378" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="30" LOG_CI_END="0.1042216015682086" LOG_CI_START="-0.36834429978663935" LOG_EFFECT_SIZE="-0.13206134910921535" MODIFIED="2013-01-21 11:00:20 +0000" MODIFIED_BY="[Empty name]" ORDER="52546" O_E="0.0" SE="0.27758754969477617" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="500" TOTAL_2="527" VAR="0.07705484774554983" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.1877312433528213" CI_START="0.6269057219597041" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1711111111111112" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="18" I2="0.0" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="0.3399939690791791" LOG_CI_START="-0.2027977662047732" LOG_EFFECT_SIZE="0.06859810143720296" METHOD="MH" MODIFIED="2013-01-31 15:32:48 +0000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="1.0" P_Q="1.0" P_Z="0.6203170283873639" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="500" TOTAL_2="527" WEIGHT="100.0" Z="0.4954010884281722">
<NAME>No episiotomy wound - further tear: 1st degree tear</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.1877312433528213" CI_START="0.6269057219597041" EFFECT_SIZE="1.1711111111111112" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="18" LOG_CI_END="0.3399939690791791" LOG_CI_START="-0.2027977662047732" LOG_EFFECT_SIZE="0.06859810143720296" MODIFIED="2013-01-21 11:02:05 +0000" MODIFIED_BY="[Empty name]" ORDER="52547" O_E="0.0" SE="0.3188385521682164" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="500" TOTAL_2="527" VAR="0.10165802234872444" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.0535965962197564" CI_START="0.9763273958608741" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0142264150943396" ESTIMABLE="YES" EVENTS_1="459" EVENTS_2="477" I2="0.0" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="0.02267435891142935" LOG_CI_START="-0.010404524164079101" LOG_EFFECT_SIZE="0.006134917373675131" METHOD="MH" MODIFIED="2013-01-31 15:33:42 +0000" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="1.0" P_Q="1.0" P_Z="0.4672243647990466" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="500" TOTAL_2="527" WEIGHT="100.0" Z="0.727002606048389">
<NAME>Episiotomy wound - no further tear</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours no enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0535965962197564" CI_START="0.9763273958608741" EFFECT_SIZE="1.0142264150943396" ESTIMABLE="YES" EVENTS_1="459" EVENTS_2="477" LOG_CI_END="0.02267435891142935" LOG_CI_START="-0.010404524164079101" LOG_EFFECT_SIZE="0.006134917373675131" MODIFIED="2013-01-21 11:03:26 +0000" MODIFIED_BY="[Empty name]" ORDER="52548" O_E="0.0" SE="0.019430699661665732" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="500" TOTAL_2="527" VAR="3.775520893418568E-4" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.379583965376982" CI_START="0.010144240282339605" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.21077844311377245" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-001.17" LOG_CI_END="0.6414328570514453" LOG_CI_START="-1.9937804723903498" LOG_EFFECT_SIZE="-0.6761738076694522" METHOD="MH" MODIFIED="2013-01-31 15:34:46 +0000" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="1.0" P_Q="1.0" P_Z="0.31450174934104447" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="500" TOTAL_2="527" WEIGHT="100.0" Z="1.0058208916256257">
<NAME>Episiotomy wound - further tear: 3rd degree tear</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.379583965376982" CI_START="0.010144240282339605" EFFECT_SIZE="0.21077844311377245" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6414328570514453" LOG_CI_START="-1.9937804723903498" LOG_EFFECT_SIZE="-0.6761738076694522" MODIFIED="2013-01-21 11:04:34 +0000" MODIFIED_BY="[Empty name]" ORDER="52549" O_E="0.0" SE="1.5479373542304704" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="500" TOTAL_2="527" VAR="2.3961100526220287" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.0561165029218205" CI_START="0.565738384747496" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.314900153609831" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-001.18" LOG_CI_END="0.4851699060592996" LOG_CI_START="-0.2473843538413771" LOG_EFFECT_SIZE="0.11889277610896128" METHOD="MH" MODIFIED="2013-01-31 15:35:41 +0000" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="1.0" P_Q="1.0" P_Z="0.5246459895163784" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="217" TOTAL_2="214" WEIGHT="100.0" Z="0.6362001341092277">
<NAME>One-minute Apgar &lt; 7</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.0561165029218205" CI_START="0.565738384747496" EFFECT_SIZE="1.314900153609831" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" LOG_CI_END="0.4851699060592996" LOG_CI_START="-0.2473843538413771" LOG_EFFECT_SIZE="0.11889277610896128" ORDER="52529" O_E="0.0" SE="0.43030599846772666" STUDY_ID="STD-Cuervo-2006" TOTAL_1="217" TOTAL_2="214" VAR="0.18516325231730715" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.0561165029218205" CI_START="0.565738384747496" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.314900153609831" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-001.19" LOG_CI_END="0.4851699060592996" LOG_CI_START="-0.2473843538413771" LOG_EFFECT_SIZE="0.11889277610896128" METHOD="MH" MODIFIED="2013-01-31 15:36:30 +0000" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="1.0" P_Q="1.0" P_Z="0.5246459895163784" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="217" TOTAL_2="214" WEIGHT="100.0" Z="0.6362001341092277">
<NAME>Five-minute Apgar &lt; 7</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.0561165029218205" CI_START="0.565738384747496" EFFECT_SIZE="1.314900153609831" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" LOG_CI_END="0.4851699060592996" LOG_CI_START="-0.2473843538413771" LOG_EFFECT_SIZE="0.11889277610896128" ORDER="52530" O_E="0.0" SE="0.43030599846772666" STUDY_ID="STD-Cuervo-2006" TOTAL_1="217" TOTAL_2="214" VAR="0.18516325231730715" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.7476997491475913" CI_START="0.17055167561570525" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3571014492753623" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="23" I2="0.0" I2_Q="0.0" ID="CMP-001.20" LOG_CI_END="-0.12627276505859686" LOG_CI_START="-0.768144009431138" LOG_EFFECT_SIZE="-0.4472083872448675" METHOD="MH" MODIFIED="2013-01-21 13:27:56 +0000" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="1.0" P_Q="1.0" P_Z="0.006312029830642645" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="75" TOTAL_2="77" WEIGHT="100.0" Z="2.7311157502966603">
<NAME>Faecal soiling during delivery</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enemas</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7476997491475912" CI_START="0.17055167561570525" EFFECT_SIZE="0.3571014492753623" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="23" LOG_CI_END="-0.12627276505859694" LOG_CI_START="-0.768144009431138" LOG_EFFECT_SIZE="-0.4472083872448675" MODIFIED="2013-01-21 11:11:53 +0000" MODIFIED_BY="[Empty name]" ORDER="43" O_E="0.0" SE="0.3770383462583334" STUDY_ID="STD-Clarke-2007" TOTAL_1="75" TOTAL_2="77" VAR="0.1421579145492189" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="21.47164214914155" CI_END="187.10033096881932" CI_START="-131.01429910915448" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="28.043015929832425" ESTIMABLE="YES" I2="95.34269436378446" I2_Q="0.0" ID="CMP-001.21" MODIFIED="2013-01-21 13:29:07 +0000" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="3.5910449626141983E-6" P_Q="1.0" P_Z="0.7296759853064345" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="12572.726694519028" TOTALS="YES" TOTAL_1="575" TOTAL_2="604" UNITS="" WEIGHT="100.0" Z="0.3455565764258148">
<NAME>Duration of labour (minutes)</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enemas</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<CONT_DATA CI_END="175.86859302063385" CI_START="48.13140697936615" EFFECT_SIZE="112.0" ESTIMABLE="YES" MEAN_1="504.7" MEAN_2="392.7" MODIFIED="2013-01-21 11:08:55 +0000" MODIFIED_BY="[Empty name]" ORDER="41" SD_1="200.86" SD_2="200.86" SE="32.58661563397142" STUDY_ID="STD-Clarke-2007" TOTAL_1="75" TOTAL_2="77" WEIGHT="48.30234971048796"/>
<CONT_DATA CI_END="-25.11577387458012" CI_START="-75.68422612541994" EFFECT_SIZE="-50.400000000000034" ESTIMABLE="YES" MEAN_1="409.4" MEAN_2="459.8" MODIFIED="2013-01-21 11:08:55 +0000" MODIFIED_BY="[Empty name]" ORDER="52550" SD_1="215.9" SD_2="196.4" SE="12.900352417115142" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="500" TOTAL_2="527" WEIGHT="51.69765028951204"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="12.957682509829388" CI_START="-2.557682509829382" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="5.200000000000003" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.22" MODIFIED="2013-01-21 13:29:52 +0000" MODIFIED_BY="[Empty name]" NO="22" P_CHI2="1.0" P_Q="1.0" P_Z="0.18892352207193433" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="176" TOTAL_2="171" UNITS="" WEIGHT="100.0" Z="1.3137702795512363">
<NAME>Duration of labour (second stage)</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<CONT_DATA CI_END="12.95768250982939" CI_START="-2.557682509829383" EFFECT_SIZE="5.200000000000003" ESTIMABLE="YES" MEAN_1="43.2" MEAN_2="38.0" MODIFIED="2013-01-21 11:09:07 +0000" MODIFIED_BY="[Empty name]" ORDER="52551" SD_1="37.23" SD_2="36.5" SE="3.9580740110639763" STUDY_ID="STD-Cuervo-2006" TOTAL_1="176" TOTAL_2="171" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.10221613472021777" CI_START="-0.10221613472021777" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.23" MODIFIED="2013-01-21 13:41:35 +0000" MODIFIED_BY="[Empty name]" NO="23" P_CHI2="1.0" P_Q="1.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="0.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="500" TOTAL_2="527" UNITS="" WEIGHT="100.0" Z="0.0">
<NAME>Parturients' levels of satisfaction (Likert scale)</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours no enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours enema</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.10221613472021777" CI_START="-0.10221613472021777" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="3.58" MEAN_2="3.58" MODIFIED="2013-01-21 11:14:39 +0000" MODIFIED_BY="[Empty name]" ORDER="52552" SD_1="0.78" SD_2="0.89" SE="0.05215204744907845" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="500" TOTAL_2="527" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.2562357696489952" CI_START="0.08376423035100465" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.16999999999999993" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.24" MODIFIED="2013-01-21 13:42:34 +0000" MODIFIED_BY="[Empty name]" NO="24" P_CHI2="1.0" P_Q="1.0" P_Z="1.1165726185562217E-4" Q="0.0" RANDOM="NO" SCALE="0.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="500" TOTAL_2="527" UNITS="" WEIGHT="100.0" Z="3.8637548980893346">
<NAME>Labour attendants' levels of satisfaction (Likert scale)</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours no enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours enema</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.2562357696489952" CI_START="0.08376423035100465" EFFECT_SIZE="0.16999999999999993" ESTIMABLE="YES" MEAN_1="3.5" MEAN_2="3.33" MODIFIED="2013-01-21 11:16:06 +0000" MODIFIED_BY="[Empty name]" ORDER="52553" SD_1="0.69" SD_2="0.72" SE="0.04399865014317203" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="500" TOTAL_2="527" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.3743679981151182" CI_START="0.1456320018848823" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.26000000000000023" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.25" MODIFIED="2013-01-21 13:42:55 +0000" MODIFIED_BY="[Empty name]" NO="25" P_CHI2="1.0" P_Q="1.0" P_Z="8.361598944969374E-6" Q="0.0" RANDOM="NO" SCALE="0.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="500" TOTAL_2="527" UNITS="" WEIGHT="100.0" Z="4.455710027095888">
<NAME>Accoucheurs' levels of satisfaction (Likert scale)</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.3743679981151182" CI_START="0.1456320018848823" EFFECT_SIZE="0.26000000000000023" ESTIMABLE="YES" MEAN_1="3.56" MEAN_2="3.3" MODIFIED="2013-01-21 11:17:10 +0000" MODIFIED_BY="[Empty name]" ORDER="52554" SD_1="0.91" SD_2="0.96" SE="0.05835209167986662" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="500" TOTAL_2="527" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.1981071977719418" CI_START="0.021892802228057937" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.10999999999999988" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.26" MODIFIED="2013-01-21 13:43:36 +0000" MODIFIED_BY="[Empty name]" NO="26" P_CHI2="1.0" P_Q="1.0" P_Z="0.014406115763496945" Q="0.0" RANDOM="NO" SCALE="0.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="500" TOTAL_2="527" UNITS="" WEIGHT="100.0" Z="2.4469741831701186">
<NAME>Perineorrhaphy operators' levels of satisfaction (Likert scale)</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours no enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours enema</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.1981071977719418" CI_START="0.021892802228057937" EFFECT_SIZE="0.10999999999999988" ESTIMABLE="YES" MEAN_1="3.54" MEAN_2="3.43" MODIFIED="2013-01-21 11:18:28 +0000" MODIFIED_BY="[Empty name]" ORDER="52555" SD_1="0.68" SD_2="0.76" SE="0.04495347795516666" STUDY_ID="STD-Kovavisarach-2005" TOTAL_1="500" TOTAL_2="527" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.003583988166022" CI_START="0.17761546462199573" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5965463108320251" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-001.27" LOG_CI_END="0.3018075523252587" LOG_CI_START="-0.7505192237623393" LOG_EFFECT_SIZE="-0.22435583571854026" METHOD="MH" MODIFIED="2013-01-31 15:40:49 +0000" MODIFIED_BY="[Empty name]" NO="27" P_CHI2="1.0" P_Q="1.0" P_Z="0.40330807414922587" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="182" TOTAL_2="190" WEIGHT="100.0" Z="0.8357277752915793">
<NAME>Pelvic infection: infected episiotomy</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.0035839881660213" CI_START="0.1776154646219958" EFFECT_SIZE="0.5965463108320251" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.30180755232525863" LOG_CI_START="-0.750519223762339" LOG_EFFECT_SIZE="-0.22435583571854026" MODIFIED="2013-01-21 10:39:07 +0000" MODIFIED_BY="[Empty name]" ORDER="52541" O_E="0.0" SE="0.6181419573754078" STUDY_ID="STD-Cuervo-2006" TOTAL_1="182" TOTAL_2="190" VAR="0.3820994794679005" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.8665816144178815" CI_START="0.007755399314387504" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.14910226385636222" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-001.28" LOG_CI_END="0.45736431108078035" LOG_CI_START="-2.110395836074698" LOG_EFFECT_SIZE="-0.8265157624969588" METHOD="MH" MODIFIED="2013-01-31 15:41:21 +0000" MODIFIED_BY="[Empty name]" NO="28" P_CHI2="1.0" P_Q="1.0" P_Z="0.20703725749907842" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="182" TOTAL_2="190" WEIGHT="100.0" Z="1.2617542405144377">
<NAME>Pelvic infection: vulvovaginitis</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.8665816144178815" CI_START="0.007755399314387504" EFFECT_SIZE="0.14910226385636222" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.45736431108078035" LOG_CI_START="-2.110395836074698" LOG_EFFECT_SIZE="-0.8265157624969588" MODIFIED="2013-01-21 10:40:28 +0000" MODIFIED_BY="[Empty name]" ORDER="52542" O_E="0.0" SE="1.5083150210568506" STUDY_ID="STD-Cuervo-2006" TOTAL_1="182" TOTAL_2="190" VAR="2.275014202745728" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.3130792965948808" CI_START="0.029447872348040822" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.260989010989011" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-001.29" LOG_CI_END="0.36419052143611164" LOG_CI_START="-1.530946078156528" LOG_EFFECT_SIZE="-0.5833777783602082" METHOD="MH" MODIFIED="2013-01-31 15:41:45 +0000" MODIFIED_BY="[Empty name]" NO="29" P_CHI2="1.0" P_Q="1.0" P_Z="0.2275604196670229" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="182" TOTAL_2="190" WEIGHT="100.0" Z="1.2066670394237253">
<NAME>Pelvic infection: endometritis</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.3130792965948808" CI_START="0.029447872348040822" EFFECT_SIZE="0.260989010989011" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.36419052143611164" LOG_CI_START="-1.530946078156528" LOG_EFFECT_SIZE="-0.5833777783602082" MODIFIED="2013-01-21 10:41:08 +0000" MODIFIED_BY="[Empty name]" ORDER="52543" O_E="0.0" SE="1.1132126196781806" STUDY_ID="STD-Cuervo-2006" TOTAL_1="182" TOTAL_2="190" VAR="1.2392423366107577" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="76.369211538118" CI_START="0.12837745376635443" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.1311475409836067" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.30" LOG_CI_END="1.8829183068208495" LOG_CI_START="-0.8915112423469285" LOG_EFFECT_SIZE="0.4957035322369605" METHOD="MH" MODIFIED="2013-01-31 15:42:30 +0000" MODIFIED_BY="[Empty name]" NO="30" P_CHI2="1.0" P_Q="1.0" P_Z="0.48369741525108956" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="182" TOTAL_2="190" WEIGHT="100.0" Z="0.700368167924944">
<NAME>Pelvic infection: myometritis</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="76.369211538118" CI_START="0.12837745376635443" EFFECT_SIZE="3.1311475409836067" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8829183068208495" LOG_CI_START="-0.8915112423469285" LOG_EFFECT_SIZE="0.4957035322369605" MODIFIED="2013-01-21 10:41:55 +0000" MODIFIED_BY="[Empty name]" ORDER="52544" O_E="0.0" SE="1.6297136508289145" STUDY_ID="STD-Cuervo-2006" TOTAL_1="182" TOTAL_2="190" VAR="2.655966583698109" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.003583988166022" CI_START="0.17761546462199573" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5965463108320251" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-001.31" LOG_CI_END="0.3018075523252587" LOG_CI_START="-0.7505192237623393" LOG_EFFECT_SIZE="-0.22435583571854026" METHOD="MH" MODIFIED="2013-01-31 15:43:19 +0000" MODIFIED_BY="[Empty name]" NO="31" P_CHI2="1.0" P_Q="1.0" P_Z="0.40330807414922587" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="182" TOTAL_2="190" WEIGHT="100.0" Z="0.8357277752915793">
<NAME>Urinary tract infection</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.0035839881660213" CI_START="0.1776154646219958" EFFECT_SIZE="0.5965463108320251" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.30180755232525863" LOG_CI_START="-0.750519223762339" LOG_EFFECT_SIZE="-0.22435583571854026" MODIFIED="2013-01-21 10:33:46 +0000" MODIFIED_BY="[Empty name]" ORDER="52540" O_E="0.0" SE="0.6181419573754078" STUDY_ID="STD-Cuervo-2006" TOTAL_1="182" TOTAL_2="190" VAR="0.3820994794679005" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.0355023840702222" CI_START="0.42324545710543254" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.662020905923345" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="41" I2="0.0" I2_Q="0.0" ID="CMP-001.32" LOG_CI_END="0.015151103120683447" LOG_CI_START="-0.37340769468301016" LOG_EFFECT_SIZE="-0.17912829578116335" METHOD="MH" MODIFIED="2013-01-31 15:43:44 +0000" MODIFIED_BY="[Empty name]" NO="32" P_CHI2="1.0" P_Q="1.0" P_Z="0.07074451690836171" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="291" TOTAL_2="303" WEIGHT="100.0" Z="1.8071139314183915">
<NAME>Other puerperal Infections</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.32.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-01-21 10:30:43 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="109" TOTAL_2="113" WEIGHT="0.0" Z="0.0">
<NAME>First 24 hours by interview</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-21 10:30:43 +0000" MODIFIED_BY="[Empty name]" ORDER="52537" O_E="0.0" SE="0.0" STUDY_ID="STD-Drayton-1984" TOTAL_1="109" TOTAL_2="113" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0355023840702222" CI_START="0.42324545710543254" DF="0" EFFECT_SIZE="0.662020905923345" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="41" I2="0.0" ID="CMP-001.32.02" LOG_CI_END="0.015151103120683447" LOG_CI_START="-0.37340769468301016" LOG_EFFECT_SIZE="-0.17912829578116335" MODIFIED="2013-01-21 10:30:43 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.07074451690836171" STUDIES="1" TAU2="0.0" TOTAL_1="182" TOTAL_2="190" WEIGHT="100.0" Z="1.8071139314183915">
<NAME>Infection during the first month</NAME>
<DICH_DATA CI_END="1.0355023840702222" CI_START="0.42324545710543254" EFFECT_SIZE="0.662020905923345" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="41" LOG_CI_END="0.015151103120683447" LOG_CI_START="-0.37340769468301016" LOG_EFFECT_SIZE="-0.17912829578116335" MODIFIED="2013-01-21 10:30:43 +0000" MODIFIED_BY="[Empty name]" ORDER="52538" O_E="0.0" SE="0.2282413612269589" STUDY_ID="STD-Cuervo-2006" TOTAL_1="182" TOTAL_2="190" VAR="0.05209411897473514" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="20.68090446895097" CI_START="1.0320825199906107" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="4.62" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-001.33" LOG_CI_END="1.3155695284878985" LOG_CI_START="0.013714422624352395" LOG_EFFECT_SIZE="0.6646419755561255" METHOD="MH" MODIFIED="2013-01-21 13:44:45 +0000" MODIFIED_BY="[Empty name]" NO="33" P_CHI2="1.0" P_Q="1.0" P_Z="0.045364533509765444" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="75" TOTAL_2="77" WEIGHT="100.0" Z="2.001258556096329">
<NAME>Other puerperal infections: Intrapartum infection rates</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="20.68090446895097" CI_START="1.0320825199906105" EFFECT_SIZE="4.62" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.3155695284878985" LOG_CI_START="0.013714422624352303" LOG_EFFECT_SIZE="0.6646419755561255" MODIFIED="2013-01-21 11:06:37 +0000" MODIFIED_BY="[Empty name]" ORDER="42" O_E="0.0" SE="0.7647161334709534" STUDY_ID="STD-Clarke-2007" TOTAL_1="75" TOTAL_2="77" VAR="0.5847907647907649" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.8444705922352342" CI_START="0.7254446818469755" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1567460317460319" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="28" I2="0.0" I2_Q="0.0" ID="CMP-001.34" LOG_CI_END="0.26587173533849257" LOG_CI_START="-0.13939569871151478" LOG_EFFECT_SIZE="0.06323801831348884" METHOD="MH" MODIFIED="2013-01-31 15:44:14 +0000" MODIFIED_BY="[Empty name]" NO="34" P_CHI2="1.0" P_Q="1.0" P_Z="0.5407584930123397" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="216" TOTAL_2="212" WEIGHT="100.0" Z="0.6116664105452333">
<NAME>Need for systemic antibiotics (postpartum)</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.8444705922352342" CI_START="0.7254446818469755" EFFECT_SIZE="1.1567460317460319" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="28" LOG_CI_END="0.26587173533849257" LOG_CI_START="-0.13939569871151478" LOG_EFFECT_SIZE="0.06323801831348884" MODIFIED="2013-01-21 10:43:05 +0000" MODIFIED_BY="[Empty name]" ORDER="52545" O_E="0.0" SE="0.23805609686712692" STUDY_ID="STD-Cuervo-2006" TOTAL_1="216" TOTAL_2="212" VAR="0.056670705255610916" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.1463442128427335E-32" CI_END="1.7999827826499133" CI_START="0.025053894486933983" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.21235955056179778" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" I2="100.0" I2_Q="0.0" ID="CMP-001.35" LOG_CI_END="0.25526835097225203" LOG_CI_START="-1.6011247559155892" LOG_EFFECT_SIZE="-0.6729282024716686" METHOD="MH" MODIFIED="2013-01-31 15:44:45 +0000" MODIFIED_BY="[Empty name]" NO="35" P_CHI2="0.0" P_Q="1.0" P_Z="0.15533312859393233" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="178" TOTAL_2="189" WEIGHT="100.0" Z="1.4209436957421686">
<NAME>Need for systemic antibiotics (neonatal - after hospital discharge during the first month)</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.7999827826499128" CI_START="0.025053894486933983" EFFECT_SIZE="0.21235955056179776" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.2552683509722519" LOG_CI_START="-1.6011247559155892" LOG_EFFECT_SIZE="-0.6729282024716686" ORDER="52525" O_E="0.0" SE="1.0904545002800001" STUDY_ID="STD-Cuervo-2006" TOTAL_1="178" TOTAL_2="189" VAR="1.1890910171809048" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.7081412962097207" CI_START="0.6162688289852791" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.02599914052428" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="26" I2="0.0" I2_Q="0.0" ID="CMP-001.36" LOG_CI_END="0.23252379236359863" LOG_CI_START="-0.21022979842549072" LOG_EFFECT_SIZE="0.011146996969053974" METHOD="MH" MODIFIED="2013-01-31 15:47:37 +0000" MODIFIED_BY="[Empty name]" NO="36" P_CHI2="1.0" P_Q="1.0" P_Z="0.9213842774754748" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="179" TOTAL_2="191" WEIGHT="100.0" Z="0.09869016558933041">
<NAME>Opthalmic infection (dacriocistitis or conjunctivitis in first month)</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.7081412962097207" CI_START="0.6162688289852791" EFFECT_SIZE="1.02599914052428" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="26" LOG_CI_END="0.23252379236359863" LOG_CI_START="-0.21022979842549072" LOG_EFFECT_SIZE="0.011146996969053974" ORDER="52521" O_E="0.0" SE="0.26007565089513224" STUDY_ID="STD-Cuervo-2006" TOTAL_1="179" TOTAL_2="191" VAR="0.06763934418852668" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="9.467748272355463" CI_START="0.27058049579511967" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.600558659217877" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-001.37" LOG_CI_END="0.9762467024276937" LOG_CI_START="-0.5677035117806624" LOG_EFFECT_SIZE="0.2042715953235156" METHOD="MH" MODIFIED="2013-01-31 15:48:00 +0000" MODIFIED_BY="[Empty name]" NO="37" P_CHI2="1.0" P_Q="1.0" P_Z="0.6040228341629899" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="179" TOTAL_2="191" WEIGHT="100.0" Z="0.5186241968351474">
<NAME>Skin infection (first month)</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="9.467748272355463" CI_START="0.27058049579511967" EFFECT_SIZE="1.600558659217877" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9762467024276937" LOG_CI_START="-0.5677035117806624" LOG_EFFECT_SIZE="0.2042715953235156" ORDER="52522" O_E="0.0" SE="0.9069239985028081" STUDY_ID="STD-Cuervo-2006" TOTAL_1="179" TOTAL_2="191" VAR="0.8225111390603215" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="16.936952668881997" CI_START="0.06727162575499179" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0674157303370786" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.38" LOG_CI_END="1.2288352738730899" LOG_CI_START="-1.1721680765852198" LOG_EFFECT_SIZE="0.02833359864393496" METHOD="MH" MODIFIED="2013-01-31 15:48:23 +0000" MODIFIED_BY="[Empty name]" NO="38" P_CHI2="1.0" P_Q="1.0" P_Z="0.9631045970646446" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="178" TOTAL_2="190" WEIGHT="100.0" Z="0.046258021992285174">
<NAME>Intestinal infection</NAME>
<GROUP_LABEL_1>Enema</GROUP_LABEL_1>
<GROUP_LABEL_2>No enema</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enema</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no enema</GRAPH_LABEL_2>
<DICH_DATA CI_END="16.936952668881997" CI_START="0.06727162575499179" EFFECT_SIZE="1.0674157303370786" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2288352738730899" LOG_CI_START="-1.1721680765852198" LOG_EFFECT_SIZE="0.02833359864393496" ORDER="52526" O_E="0.0" SE="1.4103612532174774" STUDY_ID="STD-Cuervo-2006" TOTAL_1="178" TOTAL_2="190" VAR="1.9891188645771734" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-02-10 16:04:28 +0000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-02-10 16:04:28 +0000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADnCAMAAAD7EqYIAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2013-02-10 16:04:28 +0000" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAATUAAAGSCAIAAAANZMEFAAATp0lEQVR42u2dMW4cxxKGFzBgONiA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2013-07-04 15:47:06 +0100" MODIFIED_BY="Lynn Hampson">
<APPENDIX ID="APP-01" MODIFIED="2013-07-04 15:47:06 +0100" MODIFIED_BY="Lynn Hampson" NO="1">
<TITLE MODIFIED="2010-02-07 20:51:07 +0000" MODIFIED_BY="[Empty name]">Search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2013-07-04 15:47:06 +0100" MODIFIED_BY="Lynn Hampson">
<P>Review authors searched the Cochrane Central Register of Controlled Trials (CENTRAL) and the Database of Abstracts of Reviews of Effectiveness (DARE) (<I>The Cochrane Library</I> 2013, Issue 5), PubMed (1966 to 31 May 2013) and LILACS (1982 to 31 May 2013) using the search strategy:</P>
<P>enema* AND (labor OR labour OR intrapartum OR delivery OR pregnan*).</P>
<P>Review authors also searched the following on 31 May 2013 using the word 'enema':</P>
<UL>
<LI>Search Portal of the International Clinical Trials Registry Platform (<A HREF="http://www.who.int/ictrp/">ICTRP</A>)</LI>
<LI>Health Technology Assessment Program (<A HREF="http://www.hta.ac.uk/">HTA</A>) [United Kingdom]</LI>
<LI>
<A HREF="http://www.mrc.ac.uk/index.htm">Medical Research Council</A> [United Kingdom]</LI>
<LI>
<A HREF="http://www.wellcome.ac.uk">The Wellcome Trust</A> [United Kingdom]</LI>
</UL>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2013-07-04 11:04:10 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2013-02-20 14:31:23 +0000" MODIFIED_BY="[Empty name]">Methods to be used in future updates</TITLE>
<APPENDIX_BODY MODIFIED="2013-07-04 11:04:10 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Data extraction and management  </HEADING>
<P>We will design a form to extract data. For eligible studies, at least two review authors will extract the data using the agreed form. We will resolve discrepancies through discussion or, if required, we will consult the third author. We will enter data into Review Manager software (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>) and check for accuracy.</P>
<P>When information regarding any of the above is unclear, we will attempt to contact authors of the original reports to provide further details.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of risk of bias in included studies  </HEADING>
<P>Two review authors will independently assess risk of bias for each study using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We will resolve any disagreement by discussion or by involving a third author.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Random sequence generation (checking for possible selection bias)</HEADING>
<P>We will describe for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.</P>
<P>We will assess the method as:</P>
<UL>
<LI>low risk of bias (any truly random process, e.g. random number table; computer random number generator),</LI>
<LI>high risk of bias (any non-random process, e.g. odd or even date of birth; hospital or clinic record number) or,</LI>
<LI>unclear risk of bias.   </LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4"> (2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We will describe for each included study the method used to conceal allocation to interventions prior to assignment and will assess whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We will assess the methods as:</P>
<UL>
<LI>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk of bias (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear risk of bias.   </LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.1) Blinding of participants and personnel (checking for possible performance bias)</HEADING>
<P>We will describe for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We will consider that studies are at low risk of bias if they were blinded, or if we judge that the lack of blinding would be unlikely to affect results. We will assess blinding separately for different outcomes or classes of outcomes.</P>
<P>We will assess the methods as:</P>
<UL>
<LI>low, high or unclear risk of bias for participants;</LI>
<LI>low, high or unclear risk of bias for personnel;</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.2) Blinding of outcome assessment (checking for possible detection bias)</HEADING>
<P>We will describe for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received.  We will assess blinding separately for different outcomes or classes of outcomes.</P>
<P>We will assess methods used to blind outcome assessment as:</P>
<UL>
<LI>low, high or unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data)</HEADING>
<P>We will describe for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We will state whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes.  Where sufficient information is reported, or can be supplied by the trial authors, we will re-include missing data in the analyses which we undertake.</P>
<P>We will assess methods as:</P>
<UL>
<LI>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups);</LI>
<LI>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; &#8216;as treated&#8217; analysis done with substantial departure of intervention received from that assigned at randomization);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting (checking for reporting bias)</HEADING>
<P>We will describe for each included study how we investigated the possibility of selective outcome reporting bias and what we found.</P>
<P>We will assess the methods as:</P>
<UL>
<LI>low risk of bias (where it is clear that all of the study&#8217;s pre-specified outcomes and all expected outcomes of interest to the review have been reported);</LI>
<LI>high risk of bias (where not all the study&#8217;s pre-specified outcomes have been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other bias (checking for bias due to problems not covered by 1 to 5 above)</HEADING>
<P>We will describe for each included study any important concerns we have about other possible sources of bias.</P>
<P>We will assess whether each study was free of other problems that could put it at risk of bias:</P>
<UL>
<LI>low risk of other bias;</LI>
<LI>high risk of other bias;</LI>
<LI>unclear whether there is risk of other bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>We will make explicit judgements about whether studies are at high risk of bias, according to the criteria given in the Handbook (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). With reference to (1) to (6) above, we will assess the likely magnitude and direction of the bias and whether we consider it is likely to impact on the findings.  We will explore the impact of the level of bias through undertaking sensitivity analyses - <I>see </I>
<LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Measures of treatment effect  </HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data</HEADING>
<P>For dichotomous data, we will present results as summary risk ratio with 95% confidence intervals. </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>For continuous data, we will use the mean difference if outcomes are measured in the same way between trials. We will use the standardised mean difference to combine trials that measure the same outcome, but use different methods.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Unit of analysis issues  </HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Cluster-randomised trials</HEADING>
<P>We will include cluster-randomised trials in the analyses along with individually randomised trials. We will adjust their<I> </I>sample sizes<I> </I>using the methods described in the Handbook using an estimate of the intracluster correlation co-efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster-randomised trials and individually-randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely.</P>
<P>We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity<I> </I>analysis to investigate the effects of the randomisation unit.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cross-over trials</HEADING>
<P>This study design is not eligible for inclusion in this review.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dealing with missing data  </HEADING>
<P>For included studies, we will note levels of attrition. We will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis.</P>
<P>For all outcomes, we will carry out analyses, as far as possible, on an intention-to-treat basis, i.e. we will attempt to include all participants randomised to each group in the analyses, and all participants will be analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial will be the number randomised minus any participants whose outcomes are known to be missing.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of heterogeneity  </HEADING>
<P>We will assess statistical heterogeneity in each meta-analysis using the T<SUP>2</SUP>, I² and Chi² statistics. We will regard heterogeneity as substantial if I<SUP>2</SUP> is greater than 30% and either T<SUP>2</SUP> is greater than zero, or there is a low P-value (&lt; 0.10) in the Chi² test for heterogeneity.<B> </B>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of reporting biases  </HEADING>
<P>If there are 10 or more studies in the meta-analysis we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Data synthesis  </HEADING>
<P>We will carry out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>). We will use fixed-effect meta-analysis for combining data where it is reasonable to assume that studies are estimating the same underlying treatment effect: i.e. where trials are examining the same intervention, and the trials&#8217; populations and methods are judged sufficiently similar. If there is clinical heterogeneity sufficient to expect that the underlying treatment effects differ between trials, or if substantial statistical heterogeneity is detected, we will use random-effects meta-analysis to produce an overall summary if an average treatment effect across trials is considered clinically meaningful. The random-effects summary will be treated as the average range of possible treatment effects and we will discuss the clinical implications of treatment effects differing between trials. If the average treatment effect is not clinically meaningful we will not combine trials.</P>
<P>If we use random-effects analyses, the results will be presented as the average treatment effect with 95% confidence intervals, and the estimates of  T<SUP>2</SUP> and I<SUP>2</SUP>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis and investigation of heterogeneity  </HEADING>
<P>If we identify substantial heterogeneity, we will investigate it using subgroup analyses and sensitivity analyses. We will consider whether an overall summary is meaningful and, if it is, use random-effects analysis to produce it.</P>
<P>We plan to carry out the following subgroup analyses:</P>
<P>1. Parity (primiparous versus non-primiparous).</P>
<P>2. Gestational age.</P>
<P>The following primary outcomes will be used in subgroup analyses:</P>
<OL>
<LI>Complications of episiotomy and perineal tears.</LI>
<LI>Endometritis.</LI>
<LI>Neonatal infections.</LI>
</OL>
<P>We will assess subgroup differences by interaction tests available within RevMan (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>). We will report the results of subgroup analyses quoting the &#967;2 statistic and p-value, and the interaction test I² value.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sensitivity analysis  </HEADING>
<P>In the event of significant heterogeneity, we will perform sensitivity analysis excluding trials with greater risk of bias to determine the effect on the results. Studies with high or unclear risk of bias for selection and/or attrition bias will be considered at high risk of bias and excluded in sensitivity analyses.</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>